<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Synthetic Biology</title>
<link href="https://hdl.handle.net/1721.1/18185" rel="alternate"/>
<subtitle/>
<id>https://hdl.handle.net/1721.1/18185</id>
<updated>2026-04-10T15:59:19Z</updated>
<dc:date>2026-04-10T15:59:19Z</dc:date>
<entry>
<title>10K GENES PROJECT 2017-50</title>
<link href="https://hdl.handle.net/1721.1/112699" rel="alternate"/>
<author>
<name>Pownall, Scott</name>
</author>
<author>
<name>Gandall, Keoni</name>
</author>
<id>https://hdl.handle.net/1721.1/112699</id>
<updated>2019-04-12T23:01:42Z</updated>
<published>2017-12-11T00:00:00Z</published>
<summary type="text">10K GENES PROJECT 2017-50
Pownall, Scott; Gandall, Keoni
The 10K Genes Project is a BioBricks Foundation project aimed to synthesize and make freely available DNA in partnership with Twist Bioscience. Anyone around the world may request DNA to be synthesized through the 10K Genes Project as long as it is freely available to the scientific community. This document represents the week 50 of 2017 10K Genes Project order.
</summary>
<dc:date>2017-12-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>10K GENES PROJECT 2017-48</title>
<link href="https://hdl.handle.net/1721.1/112619" rel="alternate"/>
<author>
<name>Gandall, Keoni</name>
</author>
<author>
<name>Qi, Stanley</name>
</author>
<author>
<name>Henderson, Zavier</name>
</author>
<author>
<name>Cravens, Aaron</name>
</author>
<author>
<name>Ambati, Adarsh</name>
</author>
<id>https://hdl.handle.net/1721.1/112619</id>
<updated>2019-04-12T11:28:52Z</updated>
<published>2017-12-06T00:00:00Z</published>
<summary type="text">10K GENES PROJECT 2017-48
Gandall, Keoni; Qi, Stanley; Henderson, Zavier; Cravens, Aaron; Ambati, Adarsh
The 10K Genes Project is a BioBricks Foundation project aimed to synthesize and make freely available DNA encoding useful biological functions in partnership with Twist Bioscience. Anyone around the world may request DNA to be synthesized through the 10K Genes Project as long as the DNA can then be made freely available to the public. This document represents the DNA ordered during week 48 of 2017 10K Genes Project order.
</summary>
<dc:date>2017-12-06T00:00:00Z</dc:date>
</entry>
<entry>
<title>Draft OpenMTA 11 June 2017, for comment</title>
<link href="https://hdl.handle.net/1721.1/111012" rel="alternate"/>
<author>
<name>Kahl, Linda</name>
</author>
<id>https://hdl.handle.net/1721.1/111012</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2017-08-24T00:00:00Z</published>
<summary type="text">Draft OpenMTA 11 June 2017, for comment
Kahl, Linda
The Open Material Transfer Agreement (OpenMTA) is designed to allow researchers to share materials on an open basis while working within the practical realities of technology transfer. Our goal it to help reduce transaction costs, support collaboration among researchers across institutional and international boundaries, promote access to materials for researchers in less privileged institutions and world regions, and provide an avenue for researchers and their institutions to be credited for materials made openly available. The OpenMTA was developed as a collaborative effort led by the BioBricks Foundation and OpenPlant Synthetic Biology Research Centre, with input from researchers, technology transfer professionals, legal experts, social scientists and other stakeholders. Design goals for the OpenMTA include access, attribution, reuse, redistribution, and nondiscrimination, in line with open access and open data principles. A proposed draft of the OpenMTA Master Agreement is herewith made available for public review and comment.  Please send comments to Linda Kahl via linda@biobricks.org.
</summary>
<dc:date>2017-08-24T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC #111: Inducible expression vector with His tag fusion for purification of RFC25 parts</title>
<link href="https://hdl.handle.net/1721.1/111011" rel="alternate"/>
<author>
<name>Husser, Mathieu</name>
</author>
<author>
<name>Narcross, Lauren</name>
</author>
<author>
<name>Sundarakrishnan, Adithi</name>
</author>
<id>https://hdl.handle.net/1721.1/111011</id>
<updated>2019-04-11T11:22:25Z</updated>
<published>2017-08-24T00:00:00Z</published>
<summary type="text">BBF RFC #111: Inducible expression vector with His tag fusion for purification of RFC25 parts
Husser, Mathieu; Narcross, Lauren; Sundarakrishnan, Adithi
This Request For Comments (RFC) describes a new expression vector based on the pET expression system and designed for BioBrick RFC25 parts. This design includes all the features of pET expression vectors with a new origin of replication, resistance marker and Multiple Cloning Site (MCS). This MCS contains new restriction sites and a 5’ poly- histidine tag that allows the purification of expressed RFC25 parts. Previous attempts have been prevented by restriction site incompatibility, but using RFC25 parts and their restriction sites enables 5’ fusion to these parts. This new expression vector enables the cloning of RFC25 parts with a 5’ His tag in a single step. This allows the inducible expression of these parts and the easy purification of protein products.
</summary>
<dc:date>2017-08-24T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 112: Synthetic Biology Open Language (SBOL) Version 2.1.0</title>
<link href="https://hdl.handle.net/1721.1/105278" rel="alternate"/>
<author>
<name>Beal, Jacob</name>
</author>
<author>
<name>Cox, Robert Sidney</name>
</author>
<author>
<name>Grünberg, Raik</name>
</author>
<author>
<name>McLaughlin, James</name>
</author>
<author>
<name>Nguyen, Tramy</name>
</author>
<author>
<name>Macklin, Chris</name>
</author>
<author>
<name>Bissell, Michael</name>
</author>
<author>
<name>Madsen, Curtis</name>
</author>
<author>
<name>Roehner, Nicholas</name>
</author>
<author>
<name>Oberortner, Ernst</name>
</author>
<author>
<name>Misirli, Goksel</name>
</author>
<author>
<name>Clancy, Kevin</name>
</author>
<author>
<name>Pocock, Matthew</name>
</author>
<author>
<name>Zhang, Zhen</name>
</author>
<author>
<name>Myers, Chris</name>
</author>
<author>
<name>Zhang, Michael</name>
</author>
<author>
<name>Samineni, Meher</name>
</author>
<author>
<name>Zundel, Zach</name>
</author>
<author>
<name>Bartley, Bryan</name>
</author>
<author>
<name>Choi, Kiri</name>
</author>
<author>
<name>Gennari, John H.</name>
</author>
<author>
<name>Sauro, Herbert</name>
</author>
<id>https://hdl.handle.net/1721.1/105278</id>
<updated>2019-04-11T02:22:32Z</updated>
<published>2016-11-10T00:00:00Z</published>
<summary type="text">BBF RFC 112: Synthetic Biology Open Language (SBOL) Version 2.1.0
Beal, Jacob; Cox, Robert Sidney; Grünberg, Raik; McLaughlin, James; Nguyen, Tramy; Macklin, Chris; Bissell, Michael; Madsen, Curtis; Roehner, Nicholas; Oberortner, Ernst; Misirli, Goksel; Clancy, Kevin; Pocock, Matthew; Zhang, Zhen; Myers, Chris; Zhang, Michael; Samineni, Meher; Zundel, Zach; Bartley, Bryan; Choi, Kiri; Gennari, John H.; Sauro, Herbert
The Synthetic Biology Open Language (SBOL) has been developed as a standard to support the specification and exchange of biological design information.
BBF RFC 112 (the SBOL 2.1.0 standard) replaces BBF RFC 108 (the SBOL 2.0 standard), as well as the minor update SBOL 2.0.1.
</summary>
<dc:date>2016-11-10T00:00:00Z</dc:date>
</entry>
<entry>
<title>Should We Synthesize A Human Genome?</title>
<link href="https://hdl.handle.net/1721.1/102449" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Zoloth, Laurie</name>
</author>
<id>https://hdl.handle.net/1721.1/102449</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2016-05-10T00:00:00Z</published>
<summary type="text">Should We Synthesize A Human Genome?
Endy, Drew; Zoloth, Laurie
Given that human genome synthesis is a technology that could be used to completely redefine the core of what now joins all of humanity together as a species, we argue that discussions of making such capacities real, like today's meeting at Harvard, should not take place without open and advance consideration of whether and under what circumstances it is morally right to proceed.
</summary>
<dc:date>2016-05-10T00:00:00Z</dc:date>
</entry>
<entry>
<title>Cellular Computing, ISAT Summer Study, August 1996</title>
<link href="https://hdl.handle.net/1721.1/101009" rel="alternate"/>
<author>
<name>Knight, Thomas</name>
</author>
<author>
<name>Matsudaira, Paul</name>
</author>
<id>https://hdl.handle.net/1721.1/101009</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2016-01-27T00:00:00Z</published>
<summary type="text">Cellular Computing, ISAT Summer Study, August 1996
Knight, Thomas; Matsudaira, Paul
Create and exploit a novel technology for information processing and manufacturing by controlling processes in living cells.
Final slide deck from very early (1996) DARPA ISAT study. This seminal effort helped create foundation for the 2003 DARPA ISAT on synthetic biology and other activities.
</summary>
<dc:date>2016-01-27T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 108: Synthetic Biology Open Language (SBOL) Version 2.0.0</title>
<link href="https://hdl.handle.net/1721.1/98369" rel="alternate"/>
<author>
<name>Bartley, Bryan</name>
</author>
<author>
<name>Beal, Jacob</name>
</author>
<author>
<name>Clancy, Kevin</name>
</author>
<author>
<name>Misirli, Goksel</name>
</author>
<author>
<name>Roehner, Nicholas</name>
</author>
<author>
<name>Sauro, Herbert</name>
</author>
<author>
<name>Oberortner, Ernst</name>
</author>
<author>
<name>Madsen, Curtis</name>
</author>
<author>
<name>Pocock, Matthew</name>
</author>
<author>
<name>Wipat, Anil</name>
</author>
<author>
<name>Nguyen, Tramy</name>
</author>
<author>
<name>Zhang, Zhen</name>
</author>
<author>
<name>Myers, Chris</name>
</author>
<author>
<name>Gennari, John H.</name>
</author>
<author>
<name>Bissell, Michael</name>
</author>
<id>https://hdl.handle.net/1721.1/98369</id>
<updated>2019-04-12T15:26:57Z</updated>
<published>2015-09-07T00:00:00Z</published>
<summary type="text">BBF RFC 108: Synthetic Biology Open Language (SBOL) Version 2.0.0
Bartley, Bryan; Beal, Jacob; Clancy, Kevin; Misirli, Goksel; Roehner, Nicholas; Sauro, Herbert; Oberortner, Ernst; Madsen, Curtis; Pocock, Matthew; Wipat, Anil; Nguyen, Tramy; Zhang, Zhen; Myers, Chris; Gennari, John H.; Bissell, Michael
The Synthetic Biology Open Language (SBOL) has been developed as a standard to support the specification and exchange of biological design information in synthetic biology, filling a need not satisfied by other pre-existing standards.
</summary>
<dc:date>2015-09-07T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 94: Type IIS Assembly for Bacterial Transcriptional Units: A Standardized Assembly Method for Building Bacterial Transcriptional Units Using the Type IIS Restriction Enzymes BsaI and BbsI</title>
<link href="https://hdl.handle.net/1721.1/98267" rel="alternate"/>
<author>
<name>Haddock, Traci L.</name>
</author>
<author>
<name>Densmore, Douglas M.</name>
</author>
<author>
<name>Appleton, Evan</name>
</author>
<author>
<name>Carr, Swati</name>
</author>
<author>
<name>Iverson, Sonya</name>
</author>
<author>
<name>De Freitas, Monique</name>
</author>
<author>
<name>Jin, Shawn</name>
</author>
<author>
<name>Awtry, Jake</name>
</author>
<author>
<name>Desai, Devina</name>
</author>
<author>
<name>Lozanoski, Thomas</name>
</author>
<author>
<name>Shah, Pooja</name>
</author>
<author>
<name>Agarwal, Yash</name>
</author>
<author>
<name>Lewis, Kathleen</name>
</author>
<author>
<name>Pacheco, Alan</name>
</author>
<id>https://hdl.handle.net/1721.1/98267</id>
<updated>2019-04-10T09:32:07Z</updated>
<published>2015-08-28T00:00:00Z</published>
<summary type="text">BBF RFC 94: Type IIS Assembly for Bacterial Transcriptional Units: A Standardized Assembly Method for Building Bacterial Transcriptional Units Using the Type IIS Restriction Enzymes BsaI and BbsI
Haddock, Traci L.; Densmore, Douglas M.; Appleton, Evan; Carr, Swati; Iverson, Sonya; De Freitas, Monique; Jin, Shawn; Awtry, Jake; Desai, Devina; Lozanoski, Thomas; Shah, Pooja; Agarwal, Yash; Lewis, Kathleen; Pacheco, Alan
This RFC94 describes an assembly standard based on the Type IIS restriction enzymes BsaI and BbsI (also called BpiI). This assembly standard is based upon the Modular Cloning (MoClo) assembly strategy, which was introduced in 2011 by Weber et al. [1] and is based upon Golden Gate cloning [2].&#13;
In this RFC, we describe our proposed MoClo standard for generating a library of bacterial DNA parts for generating four-part transcriptional units (promoter : 5’UTR : CDS : 3’UTR). In this work, we define 5’UTRs as including ribosomal binding sites (RBS) and bi-cistronic design elements (BCDs) [3], and 3’UTRs as transcriptional terminators. The 2012-2014 BostonU iGEM teams completed this work and a more compact library has also been created based on this work [4].
</summary>
<dc:date>2015-08-28T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 107: Copyright and Licensing of BBF RFCs</title>
<link href="https://hdl.handle.net/1721.1/98266" rel="alternate"/>
<author>
<name>Beal, Jacob</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Grewal, David</name>
</author>
<author>
<name>Johnson, Richard</name>
</author>
<author>
<name>Kahl, Linda</name>
</author>
<id>https://hdl.handle.net/1721.1/98266</id>
<updated>2019-04-10T14:34:10Z</updated>
<published>2015-08-28T00:00:00Z</published>
<summary type="text">BBF RFC 107: Copyright and Licensing of BBF RFCs
Beal, Jacob; Endy, Drew; Grewal, David; Johnson, Richard; Kahl, Linda
In this BioBricks Foundation Request for Comments (BBF RFC), we update and clarify the copyright and licensing notice of BBF RFC documents.
</summary>
<dc:date>2015-08-28T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 105: The Intein standard - a universal way to modify proteins after translation</title>
<link href="https://hdl.handle.net/1721.1/96071" rel="alternate"/>
<author>
<name>Ahlmann-Eltze, Constantin</name>
</author>
<author>
<name>Bunne, Charlotte</name>
</author>
<author>
<name>Büscher, Magdalena</name>
</author>
<author>
<name>Gleixner, Jan</name>
</author>
<author>
<name>Horn, Max</name>
</author>
<author>
<name>Huhn, Anna</name>
</author>
<author>
<name>Klughammer, Nils</name>
</author>
<author>
<name>Kreft, Jakob</name>
</author>
<author>
<name>Schäfer, Elisabeth</name>
</author>
<author>
<name>Schmelas, Carolin</name>
</author>
<author>
<name>Schmitz, Silvan</name>
</author>
<author>
<name>Waldhauer, Max</name>
</author>
<author>
<name>Bayer, Philipp</name>
</author>
<author>
<name>Krämer, Stephen</name>
</author>
<author>
<name>Neugebauer, Julia</name>
</author>
<author>
<name>Wehler, Pierre</name>
</author>
<author>
<name>Beaudouin, Joel</name>
</author>
<author>
<name>Di Ventura, Barbara</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/96071</id>
<updated>2019-04-12T14:12:18Z</updated>
<published>2015-03-17T00:00:00Z</published>
<summary type="text">BBF RFC 105: The Intein standard - a universal way to modify proteins after translation
Ahlmann-Eltze, Constantin; Bunne, Charlotte; Büscher, Magdalena; Gleixner, Jan; Horn, Max; Huhn, Anna; Klughammer, Nils; Kreft, Jakob; Schäfer, Elisabeth; Schmelas, Carolin; Schmitz, Silvan; Waldhauer, Max; Bayer, Philipp; Krämer, Stephen; Neugebauer, Julia; Wehler, Pierre; Beaudouin, Joel; Di Ventura, Barbara; Eils, Roland
This Request for Comments (RFC) proposes a new standard that allows for easy and flexible cloning of intein constructs and thus makes this technology accessible to the synthetic biology community.
</summary>
<dc:date>2015-03-17T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 104: BrickClip – rapid assembly of multiple RFC10 BioBricks</title>
<link href="https://hdl.handle.net/1721.1/96070" rel="alternate"/>
<author>
<name>Trubitsyna, Maryia</name>
</author>
<author>
<name>Chan, Karen</name>
</author>
<author>
<name>Cai, Yizhi</name>
</author>
<author>
<name>Elfick, Alistair</name>
</author>
<author>
<name>French, Chris</name>
</author>
<id>https://hdl.handle.net/1721.1/96070</id>
<updated>2019-04-10T10:14:46Z</updated>
<published>2015-03-17T00:00:00Z</published>
<summary type="text">BBF RFC 104: BrickClip – rapid assembly of multiple RFC10 BioBricks
Trubitsyna, Maryia; Chan, Karen; Cai, Yizhi; Elfick, Alistair; French, Chris
This BioBrick Foundation Request for Comments (BBF RFC 104) describes a new approach to multiple part DNA assembly – BrickClip, which does not require use of any restriction enzymes, nor cloning of the parts to specific donor and acceptor vectors. BrickClip allows assembly of up to six parts from existing parts collections, including the Registry of Standard Biological Parts, in a single reaction, in any desired order. The resulting product is exactly the same as would be obtained from normal RFC10 BioBrick assembly. In contrast to other commonly used methods such as Gibson assembly, BrickClip does not require ordering new oligonucleotides for each assembly; while assembly oligonucleotides are required, these are part-specific and may be re-used in any assembly involving a given part. BrickClip is a special case of a more general assembly method – PaperClip.
</summary>
<dc:date>2015-03-17T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 106: A Standard Type IIS Syntax for Plants</title>
<link href="https://hdl.handle.net/1721.1/96069" rel="alternate"/>
<author>
<name>Rutten, Virginia</name>
</author>
<author>
<name>Munabi, Angelina</name>
</author>
<author>
<name>Riche, Fergus</name>
</author>
<author>
<name>Lewy, Guy</name>
</author>
<author>
<name>Wilson, Hugh</name>
</author>
<author>
<name>Pipan, Miha</name>
</author>
<author>
<name>Bhate, Salil</name>
</author>
<author>
<name>Nghiem, Trang-Anh</name>
</author>
<author>
<name>Kaufhold, Will</name>
</author>
<author>
<name>Haseloff, Jim</name>
</author>
<author>
<name>Rubert, Alba</name>
</author>
<author>
<name>González, Alejandra</name>
</author>
<author>
<name>Quijano, Alfredo</name>
</author>
<author>
<name>Llopis, Ivan</name>
</author>
<author>
<name>Gavaldá, Jose</name>
</author>
<author>
<name>Estellés, Lucía</name>
</author>
<author>
<name>Vásquez, Marta</name>
</author>
<author>
<name>Orzáez, Diego</name>
</author>
<author>
<name>Deal, Cara</name>
</author>
<author>
<name>Gray, Jessica</name>
</author>
<author>
<name>Spiegel, Mischa</name>
</author>
<author>
<name>Monsey, Steven</name>
</author>
<author>
<name>Middlemiss, Alistair</name>
</author>
<author>
<name>Day, Jack</name>
</author>
<author>
<name>Patron, Nicola</name>
</author>
<id>https://hdl.handle.net/1721.1/96069</id>
<updated>2019-04-12T14:13:28Z</updated>
<published>2015-03-17T00:00:00Z</published>
<summary type="text">BBF RFC 106: A Standard Type IIS Syntax for Plants
Rutten, Virginia; Munabi, Angelina; Riche, Fergus; Lewy, Guy; Wilson, Hugh; Pipan, Miha; Bhate, Salil; Nghiem, Trang-Anh; Kaufhold, Will; Haseloff, Jim; Rubert, Alba; González, Alejandra; Quijano, Alfredo; Llopis, Ivan; Gavaldá, Jose; Estellés, Lucía; Vásquez, Marta; Orzáez, Diego; Deal, Cara; Gray, Jessica; Spiegel, Mischa; Monsey, Steven; Middlemiss, Alistair; Day, Jack; Patron, Nicola
Here we define a standard syntax for assembling standard parts for expression in plant cells, extensible to all other eukaryotes. Variations of the Type IIS mediated cloning method known as Golden Gate Cloning, most notably Golden Braid (GB2.0) and Golden Gate Modular Cloning (MoClo) are in common use, particularly for the assembly of plasmids for delivery to plant cells. Many characterised plant parts compatible with Type IIS mediated assembly are available outside of the Registry of Standard Parts, as well as plasmids with the features necessary for delivery of DNA to plants cells via the shuttle chassis, Agrobacterium tumefaciens. This RFC describes a consensus Type IIS syntax for plant parts to allow assembly into complete eukaryotic transcriptional units in plasmid vectors that contain the necessary features for transfection of plant chassis. We use Marchantia polymorpha, a primitive and easy-to-engineer liverwort and Nicotiana benthamiana a model plant as exemplar chassis.
</summary>
<dc:date>2015-03-17T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 101: Logic Gene Module Standard</title>
<link href="https://hdl.handle.net/1721.1/81957" rel="alternate"/>
<author>
<name>Wang, Lingjue</name>
</author>
<author>
<name>Tong, Yin</name>
</author>
<author>
<name>Zhou, Liqun</name>
</author>
<author>
<name>Ni, Zhuangdian</name>
</author>
<author>
<name>Zhu, Xiaodan</name>
</author>
<author>
<name>Li, Hanrun</name>
</author>
<id>https://hdl.handle.net/1721.1/81957</id>
<updated>2019-04-11T11:05:54Z</updated>
<published>2013-11-01T00:00:00Z</published>
<summary type="text">BBF RFC 101: Logic Gene Module Standard
Wang, Lingjue; Tong, Yin; Zhou, Liqun; Ni, Zhuangdian; Zhu, Xiaodan; Li, Hanrun
This Request for Comments (RFC) describes a new framework for standardize logic gene relations among gene circuits. Each type of logic module in gene circuit can be summarized in a standard device in electronics. In this paper, we collect several frequently-used logic modules and the corresponding classic gene structure.
</summary>
<dc:date>2013-11-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC97: Genetic Circuit Standard 1.0</title>
<link href="https://hdl.handle.net/1721.1/81826" rel="alternate"/>
<author>
<name>Wang, Lingjue</name>
</author>
<author>
<name>Zhu, Xiaodan</name>
</author>
<author>
<name>Li, Hanrun</name>
</author>
<author>
<name>He, Huiyu</name>
</author>
<author>
<name>Ni, Zhuangdian</name>
</author>
<author>
<name>Zhou, Liqun</name>
</author>
<id>https://hdl.handle.net/1721.1/81826</id>
<updated>2019-04-09T18:32:18Z</updated>
<published>2013-10-29T00:00:00Z</published>
<summary type="text">BBF RFC97: Genetic Circuit Standard 1.0
Wang, Lingjue; Zhu, Xiaodan; Li, Hanrun; He, Huiyu; Ni, Zhuangdian; Zhou, Liqun
Current, there is well adopted documentation of biobricks. The Registry of Standard Biology Part set the standard documentation for biobrick. However, there is no standard way to document a genetic circuit, what information should be included in a description of a genetic circuit. We have therefore develop the technique standard for recording a genetic circuits. This standard will help the sharing of genetic circuits’ information among synthetic biology community.
</summary>
<dc:date>2013-10-29T00:00:00Z</dc:date>
</entry>
<entry>
<title>Open Sequence Initiative: a part submission standard to complement modern DNA assembly techniques</title>
<link href="https://hdl.handle.net/1721.1/81334" rel="alternate"/>
<author>
<name>Hammerling, Michael J.</name>
</author>
<author>
<name>Gottel, Neil R.</name>
</author>
<author>
<name>Alnahas, Razan N.</name>
</author>
<author>
<name>Slater, Ben</name>
</author>
<author>
<name>Huang, Yunle</name>
</author>
<author>
<name>Okasheh, Yousef</name>
</author>
<author>
<name>Howard, Marco</name>
</author>
<author>
<name>Mortensen, Catherine</name>
</author>
<author>
<name>Monk, Jordan</name>
</author>
<author>
<name>Detelich, Madeline</name>
</author>
<author>
<name>Lannan, Ryan S.</name>
</author>
<author>
<name>Pitaktong, Areen</name>
</author>
<author>
<name>Weaver, Evan</name>
</author>
<author>
<name>Das, Siddharth</name>
</author>
<author>
<name>Barrick, Jeffrey E.</name>
</author>
<id>https://hdl.handle.net/1721.1/81334</id>
<updated>2019-04-10T15:36:54Z</updated>
<published>2013-10-06T00:00:00Z</published>
<summary type="text">Open Sequence Initiative: a part submission standard to complement modern DNA assembly techniques
Hammerling, Michael J.; Gottel, Neil R.; Alnahas, Razan N.; Slater, Ben; Huang, Yunle; Okasheh, Yousef; Howard, Marco; Mortensen, Catherine; Monk, Jordan; Detelich, Madeline; Lannan, Ryan S.; Pitaktong, Areen; Weaver, Evan; Das, Siddharth; Barrick, Jeffrey E.
The discipline of synthetic biology emphasizes the application of engineering principles such as standardization, abstraction, modularity, and rational design to complex biological systems. The archetypical example of such standardization is BioBrick RFC[10], introduced in 2003 by Tom Knight at MIT. BioBricks are stored on a standard plasmid, pSB1C3, which contains prefix and suffix sequences flanking the DNA sequence specifying a biological part. The prefix and suffix sequences contain two pairs of 6 base-pair (bp) restriction enzyme sites (EcoRI+XbaI and SpeI+PstI), which can be used for both part assembly and quality control. BioBricks are intended to be well- characterized biological parts, such as genes or promoters, that function in a predictable fashion and can be readily combined to make complex systems. The rules of the RFC[10] BioBrick assembly method require that none of the restriction sites used in the prefix and suffix be present in the parts themselves. This requirement can be an onerous imposition for iGEM teams developing large, novel parts, such as genes or entire operons that are obtained by amplifying DNA sequences from environmental samples or microorganisms.&#13;
While iGEM teams may use methods such as site-directed mutagenesis to remove illegal restriction sites from a part's sequence, it is certainly possible that this mutation will alter the functionality of the part – a very undesirable outcome. In addition, the mutagenesis of illegal restriction sites is an unnecessary burden on teams, given the limited time and resources available to teams during each year’s iGEM competition. Efforts spent mutagenizing sites would be better spent characterizing and improving parts. This RFC proposes an alternative submission standard to eliminate these problems.
</summary>
<dc:date>2013-10-06T00:00:00Z</dc:date>
</entry>
<entry>
<title>Standard for Synthesis of Customized Peptides by Non-Ribosomal Peptide Synthetases</title>
<link href="https://hdl.handle.net/1721.1/81333" rel="alternate"/>
<author>
<name>Beer, Ralf</name>
</author>
<author>
<name>Christiansen, Tania</name>
</author>
<author>
<name>Herbst, Konrad</name>
</author>
<author>
<name>Ignatiadis, Nikos</name>
</author>
<author>
<name>Kats, Ilia</name>
</author>
<author>
<name>Kurzawa, Nils</name>
</author>
<author>
<name>Meichsner, Johanna</name>
</author>
<author>
<name>Rabe, Sophie</name>
</author>
<author>
<name>Riedel, Anja</name>
</author>
<author>
<name>Sachs, Joshua</name>
</author>
<author>
<name>Schessner, Julia</name>
</author>
<author>
<name>Schmidt, Florian</name>
</author>
<author>
<name>Walch, Philipp</name>
</author>
<author>
<name>Adlung, Lorenz</name>
</author>
<author>
<name>Genreith, Katharina</name>
</author>
<author>
<name>Georgi, Fanny</name>
</author>
<author>
<name>Heinemann, Tim</name>
</author>
<author>
<name>Meyer, Hannah</name>
</author>
<author>
<name>Niopek, Dominik</name>
</author>
<author>
<name>Di Ventura, Barbara</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/81333</id>
<updated>2019-04-10T22:01:33Z</updated>
<published>2013-10-04T00:00:00Z</published>
<summary type="text">Standard for Synthesis of Customized Peptides by Non-Ribosomal Peptide Synthetases
Beer, Ralf; Christiansen, Tania; Herbst, Konrad; Ignatiadis, Nikos; Kats, Ilia; Kurzawa, Nils; Meichsner, Johanna; Rabe, Sophie; Riedel, Anja; Sachs, Joshua; Schessner, Julia; Schmidt, Florian; Walch, Philipp; Adlung, Lorenz; Genreith, Katharina; Georgi, Fanny; Heinemann, Tim; Meyer, Hannah; Niopek, Dominik; Di Ventura, Barbara; Eils, Roland
The purpose of this RFC is to introduce a standardized framework for the engineering of customizable non-ribosomal peptide synthetases (NRPS) and their application for in vivo and in vitro synthesis of short non-ribosomal peptides (NRPs) of user-defined sequence and structure.
</summary>
<dc:date>2013-10-04T00:00:00Z</dc:date>
</entry>
<entry>
<title>HiCT: High Throughput Protocols For CPE Cloning And Transformation</title>
<link href="https://hdl.handle.net/1721.1/81332" rel="alternate"/>
<author>
<name>Beer, Ralf</name>
</author>
<author>
<name>Christiansen, Tania</name>
</author>
<author>
<name>Herbst, Konrad</name>
</author>
<author>
<name>Ignatiadis, Nikolaos</name>
</author>
<author>
<name>Kats, Ilia</name>
</author>
<author>
<name>Kurzawa, Nils</name>
</author>
<author>
<name>Meichsner, Johanna</name>
</author>
<author>
<name>Rabe, Sophie</name>
</author>
<author>
<name>Riedel, Anja</name>
</author>
<author>
<name>Sachs, Joshua</name>
</author>
<author>
<name>Schessner, Julia</name>
</author>
<author>
<name>Schmidt, Florian</name>
</author>
<author>
<name>Walch, Philipp</name>
</author>
<author>
<name>Adlung, Lorenz</name>
</author>
<author>
<name>Genereith, Katharina</name>
</author>
<author>
<name>Georgi, Fanny</name>
</author>
<author>
<name>Heinemann, Tim</name>
</author>
<author>
<name>Meyer, Hannah</name>
</author>
<author>
<name>Niopek, Dominik</name>
</author>
<author>
<name>Di Ventura, Barbara</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/81332</id>
<updated>2019-04-10T15:36:53Z</updated>
<published>2013-10-04T00:00:00Z</published>
<summary type="text">HiCT: High Throughput Protocols For CPE Cloning And Transformation
Beer, Ralf; Christiansen, Tania; Herbst, Konrad; Ignatiadis, Nikolaos; Kats, Ilia; Kurzawa, Nils; Meichsner, Johanna; Rabe, Sophie; Riedel, Anja; Sachs, Joshua; Schessner, Julia; Schmidt, Florian; Walch, Philipp; Adlung, Lorenz; Genereith, Katharina; Georgi, Fanny; Heinemann, Tim; Meyer, Hannah; Niopek, Dominik; Di Ventura, Barbara; Eils, Roland
The purpose of this RFC is to provide instructions for a rapid and cost efficient cloning and transformation method which allows for the manufacturing of multi-fragment plasmid constructs in a parallelized manner: High Throughput Circular Extension Cloning and Transformation (HiCT).&#13;
Description of construct libraries generated by the HiCT method can be found at http://2013.igem.org/Team:Heidelberg/Indigoidine.&#13;
This RFC also points out further optimization strategies with regard to construct stability, reduction of transformation background and the generation of competent cells.
</summary>
<dc:date>2013-10-04T00:00:00Z</dc:date>
</entry>
<entry>
<title>GenBrick – A Rapid Multi-Part Assembly Method for BioBricks</title>
<link href="https://hdl.handle.net/1721.1/81331" rel="alternate"/>
<author>
<name>Gasiūnaitė, Lina</name>
</author>
<author>
<name>Lewicka, Aleksandra</name>
</author>
<author>
<name>Pashkuleva, Hristiana</name>
</author>
<author>
<name>Villanueva, Hugo</name>
</author>
<author>
<name>Thornton, Harry</name>
</author>
<author>
<name>Trubitsyna, Maryia</name>
</author>
<author>
<name>French, Chris</name>
</author>
<id>https://hdl.handle.net/1721.1/81331</id>
<updated>2019-04-10T19:50:42Z</updated>
<published>2013-10-04T00:00:00Z</published>
<summary type="text">GenBrick – A Rapid Multi-Part Assembly Method for BioBricks
Gasiūnaitė, Lina; Lewicka, Aleksandra; Pashkuleva, Hristiana; Villanueva, Hugo; Thornton, Harry; Trubitsyna, Maryia; French, Chris
This BioBricks Foundation Request for Comments (BBF RFC) describes a novel approach, GenBrick, for the rapid assembly of multiple BioBrick RFC10-compatible parts in a single reaction, with completely flexible part order, without recloning or reamplification.
</summary>
<dc:date>2013-10-04T00:00:00Z</dc:date>
</entry>
<entry>
<title>The AutoAnnotator - Standardized annotation of protein-encoding BioBricks</title>
<link href="https://hdl.handle.net/1721.1/81330" rel="alternate"/>
<author>
<name>Wolf, Christopher</name>
</author>
<author>
<name>Albrecht, Florian</name>
</author>
<author>
<name>Brüggenthies, Johanna</name>
</author>
<author>
<name>Brunner, Andreas</name>
</author>
<author>
<name>Ciccone, Rosario</name>
</author>
<author>
<name>Fischer, Katrin</name>
</author>
<author>
<name>Froehlich, Fabian</name>
</author>
<author>
<name>Funke, Louise</name>
</author>
<author>
<name>Morath, Volker</name>
</author>
<author>
<name>Polte, Ingmar</name>
</author>
<author>
<name>Reichart, Leonie</name>
</author>
<author>
<name>Schneider, Philipp</name>
</author>
<author>
<name>Truong, Jeffery</name>
</author>
<id>https://hdl.handle.net/1721.1/81330</id>
<updated>2019-04-10T15:36:53Z</updated>
<published>2013-10-04T00:00:00Z</published>
<summary type="text">The AutoAnnotator - Standardized annotation of protein-encoding BioBricks
Wolf, Christopher; Albrecht, Florian; Brüggenthies, Johanna; Brunner, Andreas; Ciccone, Rosario; Fischer, Katrin; Froehlich, Fabian; Funke, Louise; Morath, Volker; Polte, Ingmar; Reichart, Leonie; Schneider, Philipp; Truong, Jeffery
For protein-encoding BioBricks a large number of useful parameters, such as the amino acid sequence or the molecular weight, can easily be computed. Furthermore alignments against databases and predictions of various features, for instance transmembrane regions, are very interesting and informative when viewing a part. However, this information is not presented or very hard to find in most part descriptions and requires the user to use external websites to obtain it. To resolve this issue we propose a standardized table containing this information. For this purpose we developed a web tool, called the AutoAnnotator, in JavaScript gathering this information and providing the standardized table for the user to copy.
</summary>
<dc:date>2013-10-04T00:00:00Z</dc:date>
</entry>
<entry>
<title>Synthetic Biology Open Language Visual (SBOL Visual), version 1.0.0</title>
<link href="https://hdl.handle.net/1721.1/78249" rel="alternate"/>
<author>
<name>Quinn, Jacqueline</name>
</author>
<author>
<name>Beal, Jacob</name>
</author>
<author>
<name>Bhatia, Swapnil</name>
</author>
<author>
<name>Cai, Patrick</name>
</author>
<author>
<name>Chen, Joanna</name>
</author>
<author>
<name>Clancy, Kevin</name>
</author>
<author>
<name>Hillson, Nathan</name>
</author>
<author>
<name>Galdzicki, Michal</name>
</author>
<author>
<name>Maheshwari, Akshay</name>
</author>
<author>
<name>P, Umesh</name>
</author>
<author>
<name>Pocock, Matthew</name>
</author>
<author>
<name>Rodriguez, Cesar</name>
</author>
<author>
<name>Stan, Guy-Bart</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/78249</id>
<updated>2019-04-11T03:13:00Z</updated>
<published>2013-03-31T00:00:00Z</published>
<summary type="text">Synthetic Biology Open Language Visual (SBOL Visual), version 1.0.0
Quinn, Jacqueline; Beal, Jacob; Bhatia, Swapnil; Cai, Patrick; Chen, Joanna; Clancy, Kevin; Hillson, Nathan; Galdzicki, Michal; Maheshwari, Akshay; P, Umesh; Pocock, Matthew; Rodriguez, Cesar; Stan, Guy-Bart; Endy, Drew
In this BioBricks Foundation Request for Comments (BBF RFC), we specify the Synthetic Biology Open Language Visual standard (SBOL Visual) to enable consistent, human-readable depiction of genetic designs.
</summary>
<dc:date>2013-03-31T00:00:00Z</dc:date>
</entry>
<entry>
<title>Integrases, Aliens, &amp; Bill Joy</title>
<link href="https://hdl.handle.net/1721.1/78009" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/78009</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2013-03-27T00:00:00Z</published>
<summary type="text">Integrases, Aliens, &amp; Bill Joy
Endy, Drew
Research presentation on recent and unpublished work before the MIT Synthetic Biology Working Group on 24 September 2012 in MIT Building 56.
synthetic biology, engineering genetic data storage, logic, and communication systems using phage and integrases
</summary>
<dc:date>2013-03-27T00:00:00Z</dc:date>
</entry>
<entry>
<title>The GoldenBricks assembly: A standardized one-shot cloning technique for complete cassette assembly</title>
<link href="https://hdl.handle.net/1721.1/74561" rel="alternate"/>
<author>
<name>Pauthenier, Cyrille</name>
</author>
<author>
<name>El-Sayyed, Hafez</name>
</author>
<author>
<name>Rostain, William</name>
</author>
<author>
<name>Cerisy, Tristan</name>
</author>
<author>
<name>Lopez, Carolina Gallo</name>
</author>
<author>
<name>Ferreira, Raphael</name>
</author>
<author>
<name>Moreira, Jorgelindo Da Veiga</name>
</author>
<author>
<name>Souterre, Tiffany</name>
</author>
<author>
<name>Eeckhout, Joachim</name>
</author>
<author>
<name>Nogue, Pierre Yves</name>
</author>
<author>
<name>Llamosi, Artemis</name>
</author>
<author>
<name>Parutto, Pierre</name>
</author>
<author>
<name>Nikolayeva, Iryna</name>
</author>
<author>
<name>Machat, Mohamed</name>
</author>
<author>
<name>Marquet, Clement</name>
</author>
<author>
<name>Młynarczyk, Anna</name>
</author>
<author>
<name>Thelie, Aurore</name>
</author>
<author>
<name>Landrain, Thomas</name>
</author>
<author>
<name>Tolonen, Andrew</name>
</author>
<author>
<name>Pollet, Nicolas</name>
</author>
<author>
<name>Faulon, Jean-Loup</name>
</author>
<author>
<name>Jaramilo, Alfonso</name>
</author>
<id>https://hdl.handle.net/1721.1/74561</id>
<updated>2019-04-12T20:27:47Z</updated>
<published>2012-11-05T00:00:00Z</published>
<summary type="text">The GoldenBricks assembly: A standardized one-shot cloning technique for complete cassette assembly
Pauthenier, Cyrille; El-Sayyed, Hafez; Rostain, William; Cerisy, Tristan; Lopez, Carolina Gallo; Ferreira, Raphael; Moreira, Jorgelindo Da Veiga; Souterre, Tiffany; Eeckhout, Joachim; Nogue, Pierre Yves; Llamosi, Artemis; Parutto, Pierre; Nikolayeva, Iryna; Machat, Mohamed; Marquet, Clement; Młynarczyk, Anna; Thelie, Aurore; Landrain, Thomas; Tolonen, Andrew; Pollet, Nicolas; Faulon, Jean-Loup; Jaramilo, Alfonso
BBF RFC 92 proposes a new standard assembly method for the Parts Registry. The method makes one-shot cloning of a complete eukaryotic or prokaryotic cassette possible in one day while keeping compatibility with the BBF RFC 10 BioBrick assembly standard.
</summary>
<dc:date>2012-11-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Yeast Golden Gate: Standardized Assembly of S. cerevisiae Transcriptional Units</title>
<link href="https://hdl.handle.net/1721.1/73912" rel="alternate"/>
<author>
<name>Boeke, Jef</name>
</author>
<author>
<name>Mitchell, Leslie</name>
</author>
<author>
<name>Cai, Yizhi</name>
</author>
<author>
<name>Stracquadanio, Giovanni</name>
</author>
<author>
<name>Chuang, James</name>
</author>
<author>
<name>Tan, Scott</name>
</author>
<author>
<name>Heston, Margo</name>
</author>
<author>
<name>Wang, Jiarui</name>
</author>
<author>
<name>Kim, Dong Won</name>
</author>
<author>
<name>Noronha, Anne Marie</name>
</author>
<id>https://hdl.handle.net/1721.1/73912</id>
<updated>2019-04-12T21:12:08Z</updated>
<published>2012-10-11T00:00:00Z</published>
<summary type="text">Yeast Golden Gate: Standardized Assembly of S. cerevisiae Transcriptional Units
Boeke, Jef; Mitchell, Leslie; Cai, Yizhi; Stracquadanio, Giovanni; Chuang, James; Tan, Scott; Heston, Margo; Wang, Jiarui; Kim, Dong Won; Noronha, Anne Marie
BBF RFC 88 describes a new standard for the assembly of basic Saccharomyces cerevisiae transcriptional units (TUs) consisting of a promoter/5’untranslated region (UTR), open reading frame (ORF), and 3’UTR/terminator. Note that we use the term “promoter” here to refer to both the promoter and the 5’ UTR, which we currently define as a single part. Future iterations of this standard will incorporate subdivision of currently defined parts e.g. into promoter and 5’ UTR. The standard makes use of the type IIS restriction enzyme BsaI to generate standardized and user­‐defined ‘signature overhangs’, thus enabling directional and seamless TU assembly. RFC88 is supported by the Yeast Standardized Collection of Parts for Expression (SCoPE), a repository of subcloned and sequence verified parts compatible with this assembly standard. The Yeast SCoPE is currently populated by a large number of S. cerevisiae promoters and terminators that facilitate expression and characterization of non­‐native ORFs.
</summary>
<dc:date>2012-10-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>The Measurement of rho‐independent Transcription Terminator Efficiency</title>
<link href="https://hdl.handle.net/1721.1/73911" rel="alternate"/>
<author>
<name>He, Jiankui</name>
</author>
<author>
<name>Jing, Shui</name>
</author>
<author>
<name>Zhang, Mengshi</name>
</author>
<author>
<name>Liu, Xianggeng</name>
</author>
<author>
<name>Chen, Yao</name>
</author>
<author>
<name>Qie, Boyu</name>
</author>
<author>
<name>Shen, Liuxing</name>
</author>
<author>
<name>Wu, Zishan</name>
</author>
<id>https://hdl.handle.net/1721.1/73911</id>
<updated>2019-04-12T21:12:08Z</updated>
<published>2012-10-11T00:00:00Z</published>
<summary type="text">The Measurement of rho‐independent Transcription Terminator Efficiency
He, Jiankui; Jing, Shui; Zhang, Mengshi; Liu, Xianggeng; Chen, Yao; Qie, Boyu; Shen, Liuxing; Wu, Zishan
The purpose of this RFC is to provide standard methodology for the measurement of the absolute strength of terminators in bacteria. Because we have characterized the performance of terminator in E. coli and used a simple equation model, it can be expressed in PoPS.
</summary>
<dc:date>2012-10-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>The minimum information for a qualified BioBrick</title>
<link href="https://hdl.handle.net/1721.1/73910" rel="alternate"/>
<author>
<name>Zhou, Mubing</name>
</author>
<author>
<name>Zhang, Junqiu</name>
</author>
<author>
<name>He, Jiankui</name>
</author>
<id>https://hdl.handle.net/1721.1/73910</id>
<updated>2019-04-12T20:25:08Z</updated>
<published>2012-10-11T00:00:00Z</published>
<summary type="text">The minimum information for a qualified BioBrick
Zhou, Mubing; Zhang, Junqiu; He, Jiankui
Since the information of many existing BioBricks is incomplete, thus the usage of the BioBricks will be affected. It is necessary to standardize the minimum information required for a qualified BioBrick. Furthermore this standardization will reduce the time to locate and find a BioBrick. So it is essential to create a default template of storing the information of BioBricks.
</summary>
<dc:date>2012-10-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>Synthetic Biology Open Language (SBOL) Version 1.1.0</title>
<link href="https://hdl.handle.net/1721.1/73909" rel="alternate"/>
<author>
<name>Galdzicki, Michal</name>
</author>
<author>
<name>Wilson, Mandy</name>
</author>
<author>
<name>Rodriguez, Cesar A.</name>
</author>
<author>
<name>Pocock, Matthew R.</name>
</author>
<author>
<name>Oberortner, Ernst</name>
</author>
<author>
<name>Adam, Laura</name>
</author>
<author>
<name>Adler, Aaron</name>
</author>
<author>
<name>Anderson, J. Christopher</name>
</author>
<author>
<name>Beal, Jacob</name>
</author>
<author>
<name>Cai, Yizhi</name>
</author>
<author>
<name>Chandran, Deepak</name>
</author>
<author>
<name>Densmore, Douglas</name>
</author>
<author>
<name>Drory, Omri A.</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Gennari, John H.</name>
</author>
<author>
<name>Grünberg, Raik</name>
</author>
<author>
<name>Ham, Timothy S.</name>
</author>
<author>
<name>Hillson, Nathan J.</name>
</author>
<author>
<name>Johnson, Jeffrey D.</name>
</author>
<author>
<name>Kuchinsky, Allan</name>
</author>
<author>
<name>Lux, Matthew W.</name>
</author>
<author>
<name>Madsen, Curtis</name>
</author>
<author>
<name>Misirli, Goksel</name>
</author>
<author>
<name>Myers, Chris J.</name>
</author>
<author>
<name>Olguin, Carlos</name>
</author>
<author>
<name>Peccoud, Jean</name>
</author>
<author>
<name>Plahar, Hector</name>
</author>
<author>
<name>Platt, Darren</name>
</author>
<author>
<name>Roehner, Nicholas</name>
</author>
<author>
<name>Sirin, Evren</name>
</author>
<author>
<name>Smith, Trevor F.</name>
</author>
<author>
<name>Stan, Guy-Bart</name>
</author>
<author>
<name>Villabos, Alan</name>
</author>
<author>
<name>Wipat, Anil</name>
</author>
<author>
<name>Sauro, Herbert M.</name>
</author>
<id>https://hdl.handle.net/1721.1/73909</id>
<updated>2019-04-10T15:48:59Z</updated>
<published>2012-10-11T00:00:00Z</published>
<summary type="text">Synthetic Biology Open Language (SBOL) Version 1.1.0
Galdzicki, Michal; Wilson, Mandy; Rodriguez, Cesar A.; Pocock, Matthew R.; Oberortner, Ernst; Adam, Laura; Adler, Aaron; Anderson, J. Christopher; Beal, Jacob; Cai, Yizhi; Chandran, Deepak; Densmore, Douglas; Drory, Omri A.; Endy, Drew; Gennari, John H.; Grünberg, Raik; Ham, Timothy S.; Hillson, Nathan J.; Johnson, Jeffrey D.; Kuchinsky, Allan; Lux, Matthew W.; Madsen, Curtis; Misirli, Goksel; Myers, Chris J.; Olguin, Carlos; Peccoud, Jean; Plahar, Hector; Platt, Darren; Roehner, Nicholas; Sirin, Evren; Smith, Trevor F.; Stan, Guy-Bart; Villabos, Alan; Wipat, Anil; Sauro, Herbert M.
In this BioBricks Foundation Request for Comments (BBF RFC), we specify the Synthetic Biology&#13;
Open Language (SBOL) Version 1.1.0 to enable the electronic exchange of information&#13;
describing DNA components used in synthetic biology. We define:&#13;
1. the vocabulary, a set of preferred terms and&#13;
2. the core data model, a common computational representation.
</summary>
<dc:date>2012-10-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>Creating native registry functions to accommodate mutant libraries</title>
<link href="https://hdl.handle.net/1721.1/67887" rel="alternate"/>
<author>
<name>Xu, Kenneth O.</name>
</author>
<author>
<name>Walters, Eric M.</name>
</author>
<id>https://hdl.handle.net/1721.1/67887</id>
<updated>2019-04-11T09:49:11Z</updated>
<published>2011-12-29T00:00:00Z</published>
<summary type="text">Creating native registry functions to accommodate mutant libraries
Xu, Kenneth O.; Walters, Eric M.
The current registry system accommodates normal parts fairly well but has difficulty when adding mutant libraries. If all mutant offspring were added as new parts, the registry would be comprehensive but the parts registry would become filled with parts and eventually become unmanageable to navigate. If the mutants were added directly to the source’s page, it could become unwieldy and unintuitive to find. We propose a system of adding a few features to the registry that SHALL allow a user-friendly method of visualizing mutant offspring and siblings while condensing the registry as much as possible when mutants are introduced to allow for easier navigation.
</summary>
<dc:date>2011-12-29T00:00:00Z</dc:date>
</entry>
<entry>
<title>PCR - Ligation Assembly Standard for BioBrick Parts</title>
<link href="https://hdl.handle.net/1721.1/67700" rel="alternate"/>
<author>
<name>He, Tony PeiYuan</name>
</author>
<author>
<name>Campbell, Alexander</name>
</author>
<author>
<name>Zhou, Stefanie Yifan</name>
</author>
<id>https://hdl.handle.net/1721.1/67700</id>
<updated>2019-04-09T18:39:43Z</updated>
<published>2011-12-15T00:00:00Z</published>
<summary type="text">PCR - Ligation Assembly Standard for BioBrick Parts
He, Tony PeiYuan; Campbell, Alexander; Zhou, Stefanie Yifan
This Request for Comments (RFC) describes a novel method for the assembly of standard BioBrick parts. This assembly method for BioBrick parts is an improvement upon the conventional methods of BioBrick part assembly. This assembly method will involve the use of standard BioBrick restriction enzyme systems, PCR purification kit, ligase system, and a PCR polymerase system.
</summary>
<dc:date>2011-12-15T00:00:00Z</dc:date>
</entry>
<entry>
<title>Reusable rapid assembly of genetic parts for Neurospora crassa</title>
<link href="https://hdl.handle.net/1721.1/66485" rel="alternate"/>
<author>
<name>Odsen, Raymond</name>
</author>
<author>
<name>Baretta, Kayla</name>
</author>
<author>
<name>Zakrewski, Helena</name>
</author>
<author>
<name>Simpson, Michael</name>
</author>
<author>
<name>Guo, Yuan</name>
</author>
<author>
<name>Pelech, Murray</name>
</author>
<author>
<name>Foster, Adam</name>
</author>
<author>
<name>Ridgway, Douglas</name>
</author>
<author>
<name>Ellison, Michael</name>
</author>
<id>https://hdl.handle.net/1721.1/66485</id>
<updated>2019-04-10T10:38:11Z</updated>
<published>2011-10-17T00:00:00Z</published>
<summary type="text">Reusable rapid assembly of genetic parts for Neurospora crassa
Odsen, Raymond; Baretta, Kayla; Zakrewski, Helena; Simpson, Michael; Guo, Yuan; Pelech, Murray; Foster, Adam; Ridgway, Douglas; Ellison, Michael
This BBF RFC provides a method in which standardized parts can be easily created for Neurospora crassa.
</summary>
<dc:date>2011-10-17T00:00:00Z</dc:date>
</entry>
<entry>
<title>"BioSandwich", a homology-based assembly method using a library of standard parts</title>
<link href="https://hdl.handle.net/1721.1/66484" rel="alternate"/>
<author>
<name>Abbas, Yassen</name>
</author>
<author>
<name>Crossman, Allan</name>
</author>
<author>
<name>Fletcher, Eugene</name>
</author>
<author>
<name>French, Chris</name>
</author>
<author>
<name>Gibson, Clare</name>
</author>
<author>
<name>Isapanie, Sylvia</name>
</author>
<author>
<name>Kopec, Lukasz</name>
</author>
<author>
<name>Lee, Mun Ching</name>
</author>
<author>
<name>Li, Di</name>
</author>
<author>
<name>Tynan-O'Mahony, Fionn</name>
</author>
<id>https://hdl.handle.net/1721.1/66484</id>
<updated>2019-04-09T19:08:06Z</updated>
<published>2011-10-17T00:00:00Z</published>
<summary type="text">"BioSandwich", a homology-based assembly method using a library of standard parts
Abbas, Yassen; Crossman, Allan; Fletcher, Eugene; French, Chris; Gibson, Clare; Isapanie, Sylvia; Kopec, Lukasz; Lee, Mun Ching; Li, Di; Tynan-O'Mahony, Fionn
This Request for Comments (RFC) describes a strategy for using homology-based assembly methods to assemble parts from a library in any order.
</summary>
<dc:date>2011-10-17T00:00:00Z</dc:date>
</entry>
<entry>
<title>Title: Synthetic Biology Open Language (SBOL) Version 1.0.0</title>
<link href="https://hdl.handle.net/1721.1/66172" rel="alternate"/>
<author>
<name>Wipat, Anil</name>
</author>
<author>
<name>Villalobos, Alan</name>
</author>
<author>
<name>Stan, Guy-Bart</name>
</author>
<author>
<name>Smith, Trevor</name>
</author>
<author>
<name>Sauro, Herbert</name>
</author>
<author>
<name>Roehner, Nicholas</name>
</author>
<author>
<name>Pocock, Matthew</name>
</author>
<author>
<name>Plahar, Hector</name>
</author>
<author>
<name>Peccoud, Jean</name>
</author>
<author>
<name>Myers, Chris</name>
</author>
<author>
<name>Misirli, Goksel</name>
</author>
<author>
<name>Madsen, Curtis</name>
</author>
<author>
<name>Lux, Matthew</name>
</author>
<author>
<name>Kuchinsky, Allan</name>
</author>
<author>
<name>Ham, Timothy</name>
</author>
<author>
<name>Grünberg, Raik</name>
</author>
<author>
<name>Gennari, John</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Drory, Omri</name>
</author>
<author>
<name>Densmore, Douglas</name>
</author>
<author>
<name>Chandran, Deepak</name>
</author>
<author>
<name>Beal, Jacob</name>
</author>
<author>
<name>Anderson, J. Christopher</name>
</author>
<author>
<name>Adler, Aaron</name>
</author>
<author>
<name>Adam, Laura</name>
</author>
<author>
<name>Rodriguez, Cesar</name>
</author>
<author>
<name>Wilson, Mandy</name>
</author>
<author>
<name>Galdzicki, Michal</name>
</author>
<id>https://hdl.handle.net/1721.1/66172</id>
<updated>2019-04-10T07:26:40Z</updated>
<published>2011-10-03T00:00:00Z</published>
<summary type="text">Title: Synthetic Biology Open Language (SBOL) Version 1.0.0
Wipat, Anil; Villalobos, Alan; Stan, Guy-Bart; Smith, Trevor; Sauro, Herbert; Roehner, Nicholas; Pocock, Matthew; Plahar, Hector; Peccoud, Jean; Myers, Chris; Misirli, Goksel; Madsen, Curtis; Lux, Matthew; Kuchinsky, Allan; Ham, Timothy; Grünberg, Raik; Gennari, John; Endy, Drew; Drory, Omri; Densmore, Douglas; Chandran, Deepak; Beal, Jacob; Anderson, J. Christopher; Adler, Aaron; Adam, Laura; Rodriguez, Cesar; Wilson, Mandy; Galdzicki, Michal
In this BioBricks Foundation Request for Comments (BBF RFC), we specify the Synthetic Biology &#13;
Open Language (SBOL) Version 1.0.0 to enable the electronic exchange of information &#13;
describing DNA components used in synthetic biology. We define:  &#13;
1. the vocabulary, a set of preferred terms and &#13;
2. the core data model, a common computational representation.
</summary>
<dc:date>2011-10-03T00:00:00Z</dc:date>
</entry>
<entry>
<title>Assembly of BioBrick standard biological parts using three antibiotic assembly</title>
<link href="https://hdl.handle.net/1721.1/65066" rel="alternate"/>
<author>
<name>Shetty, Reshma</name>
</author>
<author>
<name>Lizarazo, Meagan</name>
</author>
<author>
<name>Rettberg, Randy</name>
</author>
<author>
<name>Knight, Thomas F., Jr.</name>
</author>
<id>https://hdl.handle.net/1721.1/65066</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2011-05-20T00:00:00Z</published>
<summary type="text">Assembly of BioBrick standard biological parts using three antibiotic assembly
Shetty, Reshma; Lizarazo, Meagan; Rettberg, Randy; Knight, Thomas F., Jr.
An underlying goal of synthetic biology is to make the process of engineering biological systems easier and more reliable. In support of this goal, we developed BioBrick assembly standard 10 to enable the construction of systems from standardized genetic parts. The BioBrick standard underpins the distributed efforts by the synthetic biology research community to develop a collection of more than 6000 standard genetic parts available from the Registry of Standard Biological Parts. Here, we describe the three antibiotic assembly method for physical composition of BioBrick parts and provide step-by-step protocols. The method relies on a combination of positive and negative selection to eliminate time- and labor-intensive steps such as column cleanup and agarose gel purification of DNA during part assembly.
This is a revised personal version of the text of the final journal article available via DOI: 10.1016/B978-0-12-385120-8.00013-9
</summary>
<dc:date>2011-05-20T00:00:00Z</dc:date>
</entry>
<entry>
<title>Detailed Information Standard</title>
<link href="https://hdl.handle.net/1721.1/60094" rel="alternate"/>
<author>
<name>Culviner, Peter</name>
</author>
<author>
<name>Pantalone, Nathaniel</name>
</author>
<author>
<name>Sagstetter, Mary</name>
</author>
<author>
<name>Sandock, Sarah</name>
</author>
<author>
<name>Vrana, Justin</name>
</author>
<author>
<name>Wu, Yue</name>
</author>
<id>https://hdl.handle.net/1721.1/60094</id>
<updated>2019-04-11T01:13:54Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Detailed Information Standard
Culviner, Peter; Pantalone, Nathaniel; Sagstetter, Mary; Sandock, Sarah; Vrana, Justin; Wu, Yue
The purpose of this standard is to increase the required information that must accompany any parts submitted to the Registry of Standard Biological Parts. This will give users of the parts better assurance of their authenticity and promote better Registry maintenance.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Measurement of bacterial promoter absolute activity and determination of dynamic performance in cell-free expression system by qPCR</title>
<link href="https://hdl.handle.net/1721.1/60093" rel="alternate"/>
<author>
<name>Olchowik, Anna</name>
</author>
<author>
<name>Lower, Michal</name>
</author>
<author>
<name>Moreno, Cherry</name>
</author>
<author>
<name>Pankowski, Jaroslaw</name>
</author>
<id>https://hdl.handle.net/1721.1/60093</id>
<updated>2019-04-11T01:13:54Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Measurement of bacterial promoter absolute activity and determination of dynamic performance in cell-free expression system by qPCR
Olchowik, Anna; Lower, Michal; Moreno, Cherry; Pankowski, Jaroslaw
The purpose of this RFC is to provide standard methodology for the measurement of the absolute strength of bacterial promoters. The absolute activity can be experimentally measured in Moles of RNA per Moles of DNA in time, and therefore it is can be expressed in PoPS [1]
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>miMeasure – a standard for miRNA binding site characterization in mammalian cells</title>
<link href="https://hdl.handle.net/1721.1/60092" rel="alternate"/>
<author>
<name>Adlung, Lorenz</name>
</author>
<author>
<name>Sabah, Jude Al</name>
</author>
<author>
<name>Bayer, Philipp</name>
</author>
<author>
<name>Berrens, Rebecca</name>
</author>
<author>
<name>Cristiano, Elena</name>
</author>
<author>
<name>Flocke, Lea</name>
</author>
<author>
<name>Kleinsorg, Stefan</name>
</author>
<author>
<name>Kolodziejczyk, Aleksandra</name>
</author>
<author>
<name>Kraemer, Stephen</name>
</author>
<author>
<name>Torre, Alejandro Macias</name>
</author>
<author>
<name>Mathur, Aastha</name>
</author>
<author>
<name>Mayilo, Dmytro</name>
</author>
<author>
<name>Neumann, Stefan</name>
</author>
<author>
<name>Niopek, Dominik</name>
</author>
<author>
<name>Pisa, Rudolf</name>
</author>
<author>
<name>Schad, Jan-Ulrich</name>
</author>
<author>
<name>Schumacher, Laura-Nadine</name>
</author>
<author>
<name>Uhlig, Thomas</name>
</author>
<author>
<name>Wu, Xiaoting</name>
</author>
<author>
<name>Keienburg, Jens</name>
</author>
<author>
<name>Boerner, Kathleen</name>
</author>
<author>
<name>Grimm, Dirk</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/60092</id>
<updated>2019-04-11T01:13:42Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">miMeasure – a standard for miRNA binding site characterization in mammalian cells
Adlung, Lorenz; Sabah, Jude Al; Bayer, Philipp; Berrens, Rebecca; Cristiano, Elena; Flocke, Lea; Kleinsorg, Stefan; Kolodziejczyk, Aleksandra; Kraemer, Stephen; Torre, Alejandro Macias; Mathur, Aastha; Mayilo, Dmytro; Neumann, Stefan; Niopek, Dominik; Pisa, Rudolf; Schad, Jan-Ulrich; Schumacher, Laura-Nadine; Uhlig, Thomas; Wu, Xiaoting; Keienburg, Jens; Boerner, Kathleen; Grimm, Dirk; Eils, Roland
This RFC proposes a standard for the quantitative characterization of miRNA binding sites (miRNA-BS) in mammalian cells. The miMeasure standard introduces a ready-to-use standard measurement plasmid (pSMB_miMeasure, BBa_K337049) enabling rapid experimental characterization of any miRNA-BS of choice. We recommend a new standard unit, RKDU (relative knock-down unit) to describe the knock-down efficiency of a miRNA-BS in a specific cell type. pSMB_miMeasure allows for an easy and fast measurement of RKDU while providing effective normalization against variance stemming from differences in transfection efficiency and from other sources.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>miTuner - a kit for microRNA based gene expression tuning in mammalian cells</title>
<link href="https://hdl.handle.net/1721.1/60091" rel="alternate"/>
<author>
<name>Adlung, Lorenz</name>
</author>
<author>
<name>Sabah, Jude Al</name>
</author>
<author>
<name>Bayer, Philipp</name>
</author>
<author>
<name>Berrens, Rebecca</name>
</author>
<author>
<name>Cristiano, Elena</name>
</author>
<author>
<name>Flocke, Lea</name>
</author>
<author>
<name>Kleinsorg, Stefan</name>
</author>
<author>
<name>Kolodziejczyk, Aleksandra</name>
</author>
<author>
<name>Kraemer, Stephen</name>
</author>
<author>
<name>Torre, Alejandro Macias</name>
</author>
<author>
<name>Mathur, Aastha</name>
</author>
<author>
<name>Mayilo, Dmytro</name>
</author>
<author>
<name>Neumann, Stefan</name>
</author>
<author>
<name>Niopek, Dominik</name>
</author>
<author>
<name>Pisa, Rudolf</name>
</author>
<author>
<name>Schad, Jan-Ulrich</name>
</author>
<author>
<name>Schumacher, Laura-Nadine</name>
</author>
<author>
<name>Uhlig, Thomas</name>
</author>
<author>
<name>Wu, Xiaoting</name>
</author>
<author>
<name>Keienburg, Jens</name>
</author>
<author>
<name>Boerner, Kathleen</name>
</author>
<author>
<name>Grimm, Dirk</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/60091</id>
<updated>2019-04-09T18:10:29Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">miTuner - a kit for microRNA based gene expression tuning in mammalian cells
Adlung, Lorenz; Sabah, Jude Al; Bayer, Philipp; Berrens, Rebecca; Cristiano, Elena; Flocke, Lea; Kleinsorg, Stefan; Kolodziejczyk, Aleksandra; Kraemer, Stephen; Torre, Alejandro Macias; Mathur, Aastha; Mayilo, Dmytro; Neumann, Stefan; Niopek, Dominik; Pisa, Rudolf; Schad, Jan-Ulrich; Schumacher, Laura-Nadine; Uhlig, Thomas; Wu, Xiaoting; Keienburg, Jens; Boerner, Kathleen; Grimm, Dirk; Eils, Roland
The purpose of this RFC is to introduce a modular expression tuning kit for use in mammalian cells. The kit enables the regulation of the gene expression of any gene of interest (GOI) based on synthetic microRNAs, endogenous microRNAs or a combination of both.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>General updating scheme for the design and construction of assembly vectors that are compatible with BBF RFC 10 and BBF RFC 28</title>
<link href="https://hdl.handle.net/1721.1/60090" rel="alternate"/>
<author>
<name>Billerbeck, Sonja</name>
</author>
<author>
<name>Zwicky, Katharina</name>
</author>
<author>
<name>Lang, Moritz</name>
</author>
<author>
<name>Pestalozzi, Luzius</name>
</author>
<author>
<name>Rosenberger, George</name>
</author>
<author>
<name>Constantinescu, Simona</name>
</author>
<author>
<name>Ambegoda, Thanuja</name>
</author>
<author>
<name>Sotiriadis, Elsa</name>
</author>
<id>https://hdl.handle.net/1721.1/60090</id>
<updated>2019-04-11T01:13:54Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">General updating scheme for the design and construction of assembly vectors that are compatible with BBF RFC 10 and BBF RFC 28
Billerbeck, Sonja; Zwicky, Katharina; Lang, Moritz; Pestalozzi, Luzius; Rosenberger, George; Constantinescu, Simona; Ambegoda, Thanuja; Sotiriadis, Elsa
BBF RFC 75 intends to link the BBF RFC 28-based combinatorial multi-part assembly method to BBF RFC 10. Its aim is to easily redesign an expression vector to make it compatible to BBF RFC 10 for the construction of fusion proteins based on BBF RFC 28. These vectors can then directly be used for expression of the fusion protein.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Documentation of BioBrick parts</title>
<link href="https://hdl.handle.net/1721.1/60089" rel="alternate"/>
<author>
<name>Slomp, Arend</name>
</author>
<author>
<name>Ekkers, David</name>
</author>
<id>https://hdl.handle.net/1721.1/60089</id>
<updated>2019-04-12T11:36:35Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Documentation of BioBrick parts
Slomp, Arend; Ekkers, David
Purpose of this RFC is to improve the information supplied by BioBrick part vendors. Reason to have this RFC is that there would be much more information available which can help improve the search time of the user. Furthermore it should supply the information in such a way that no contact is needed with the creator of the BioBrick part. It should create a default template for all information of BioBrick parts and devices.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Construction a RBS library with different translational activity</title>
<link href="https://hdl.handle.net/1721.1/60088" rel="alternate"/>
<author>
<name>Lee, Hsiao-Ching</name>
</author>
<id>https://hdl.handle.net/1721.1/60088</id>
<updated>2019-04-12T11:36:35Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Construction a RBS library with different translational activity
Lee, Hsiao-Ching
The first step in programming and controlling cell behavior is to establish a library of well-defined components, a.k.a. "biobricks", that serve as the building blocks of artificial gene networks. The main challenge in genetic circuit design lies in selecting well-matched genetic components that when coupled, reliably and consistently act in a desired behavior. Although the parameter values are calculated by model equations, it is hard to select the biobricks that reliably implements a desired cellular function with quantitative values. To overcome this problem, the RBSs were designed to control the expression of downstream genes when necessary. This protocol will describe how to generate a RBS library with different ribosome binding affinities. The degenerated primers designed for PCR are used to generate mutations in RBS regions, while the mutated RBS activity are assayed using green fluorescence protein on a low copy number plasmid. In addition, a library of RBS's with different transcriptional strength can be built to fit the specific parameter values derived from model equations. Because the reporter protein activity has a positive correlation to RBS translational activity, we can design customizable RBS translational strengths for application.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Novel Normalization Standard using Fluorescence</title>
<link href="https://hdl.handle.net/1721.1/60087" rel="alternate"/>
<author>
<name>Bukhari, Syed Habib Tahir</name>
</author>
<author>
<name>Akkineni, Ashwini Rahul</name>
</author>
<author>
<name>Ananth, Adithya</name>
</author>
<author>
<name>Gordeev, Victor</name>
</author>
<author>
<name>Grieb, Svea</name>
</author>
<author>
<name>Mansour, Sarah</name>
</author>
<author>
<name>Roth, Mareike</name>
</author>
<author>
<name>Sampathkumar, Charanya</name>
</author>
<author>
<name>Schirmer, Lucas</name>
</author>
<author>
<name>Tam, Jonathan</name>
</author>
<id>https://hdl.handle.net/1721.1/60087</id>
<updated>2019-04-11T01:13:54Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Novel Normalization Standard using Fluorescence
Bukhari, Syed Habib Tahir; Akkineni, Ashwini Rahul; Ananth, Adithya; Gordeev, Victor; Grieb, Svea; Mansour, Sarah; Roth, Mareike; Sampathkumar, Charanya; Schirmer, Lucas; Tam, Jonathan
The Biotec_Dresden Team 2010 developed an approach where two fluorescent proteins are simultaneously expressed. The fact that one reporter, in our case RFP, is constitutively expressed allows to monitor cell growth. Secondly, an inducible promoter drives the expression of the second reporter, YFP in the case of the part tested. The constitutively expressed reporter protein (R1) serves as normalization factor for the inducible reporter (R2) by simple division.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Standard for the Electronic Distribution of SBOLv Diagrams</title>
<link href="https://hdl.handle.net/1721.1/60086" rel="alternate"/>
<author>
<name>Johnson, Jeffrey</name>
</author>
<author>
<name>Galdzicki, Michal</name>
</author>
<author>
<name>Sauro, Herbert M</name>
</author>
<id>https://hdl.handle.net/1721.1/60086</id>
<updated>2019-04-09T17:25:54Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Standard for the Electronic Distribution of SBOLv Diagrams
Johnson, Jeffrey; Galdzicki, Michal; Sauro, Herbert M
A common method for publicly distributing design diagrams on the Web would enhance understanding of the mechanisms and intended function of synthetic DNA constructs. We aim to improve the usefulness of the depicted design to readers by establishing a systematic scheme for linking diagrams of synthetic biological mechanisms to reference information on the Registry of Standard Biological Parts [1]. Through the&#13;
use of standard diagrams based on SBOL-visual (BBF RFC 16) symbols, we hope to facilitate communication about synthetic DNA constructs between research groups. This standard applies the use of the established SBOLv symbols on the Web to clearly represent synthetic constructs. Linking these diagrams using http URLs to reference information at the Registry provides a method to retrieve contextual reference information about components of DNA constructs. Use of standardized diagrams in engineering promotes fast and accurate communication between researchers, which in turn promotes effective re-use of biological parts.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>A RESTful API for Supporting Automated BioBrick Model Assembly</title>
<link href="https://hdl.handle.net/1721.1/60085" rel="alternate"/>
<author>
<name>Steyn, J S</name>
</author>
<author>
<name>Boyd, R M</name>
</author>
<author>
<name>Essa, Y</name>
</author>
<author>
<name>Hall, P</name>
</author>
<author>
<name>Koh, A</name>
</author>
<author>
<name>Sheth, H</name>
</author>
<author>
<name>Tsu, D</name>
</author>
<author>
<name>Woodhouse, S</name>
</author>
<author>
<name>Hallinan, J</name>
</author>
<author>
<name>Wipat, A</name>
</author>
<author>
<name>Pocock, M R</name>
</author>
<id>https://hdl.handle.net/1721.1/60085</id>
<updated>2019-04-11T01:13:53Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">A RESTful API for Supporting Automated BioBrick Model Assembly
Steyn, J S; Boyd, R M; Essa, Y; Hall, P; Koh, A; Sheth, H; Tsu, D; Woodhouse, S; Hallinan, J; Wipat, A; Pocock, M R
Constructing simulatable models for BioBricks by hand is a complex and time-consuming task. The time taken could be reduced by using Computer Aided Design (CAD) tools to aid in designing models, but these tools need to be augmented with domain-specific knowledge. Here we propose a standard for a RESTful (Richardson, 2007) API which facilitates the discovery and publication of models of functional biological units. This API is designed to produce parts models which can be automatically combined into complete, simulatable models of entire systems.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>A New Standard to Connect BioBrick Parts for Precise Extraction of an Enzyme Digestion Product</title>
<link href="https://hdl.handle.net/1721.1/60084" rel="alternate"/>
<author>
<name>Uekusa, Kousuke</name>
</author>
<author>
<name>Iguchi, Seiko</name>
</author>
<id>https://hdl.handle.net/1721.1/60084</id>
<updated>2019-04-12T11:36:34Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">A New Standard to Connect BioBrick Parts for Precise Extraction of an Enzyme Digestion Product
Uekusa, Kousuke; Iguchi, Seiko
This BioBricks Foundation Request for Comments (BBF RFC) introduces a new standard to connect BioBrick parts using BglI site.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Building Protein Domain Based Composite Biobricks for Mammalian Expression Systems</title>
<link href="https://hdl.handle.net/1721.1/60083" rel="alternate"/>
<author>
<name>Balint, Balint L</name>
</author>
<author>
<name>Keret, Ophir</name>
</author>
<author>
<name>Brazda, Peter</name>
</author>
<author>
<name>Demeny, Mate</name>
</author>
<author>
<name>2010 Debrecen-Hungary, iGEM</name>
</author>
<id>https://hdl.handle.net/1721.1/60083</id>
<updated>2019-04-11T01:13:53Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Building Protein Domain Based Composite Biobricks for Mammalian Expression Systems
Balint, Balint L; Keret, Ophir; Brazda, Peter; Demeny, Mate; 2010 Debrecen-Hungary, iGEM
The purpose of this RFC is to describe a method that allows the design of protein domain based parts, starting with gene centered information and translate these informations into BBF RFC 25 compatible part. The method is designed to be used in mammalian expression systems.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Recombination Based Part Assembly</title>
<link href="https://hdl.handle.net/1721.1/60082" rel="alternate"/>
<author>
<name>Deming, Laura</name>
</author>
<author>
<name>Slusarczyk, Adrian</name>
</author>
<author>
<name>Jiao, Yunxin</name>
</author>
<author>
<name>iGEM, 2010 MIT</name>
</author>
<id>https://hdl.handle.net/1721.1/60082</id>
<updated>2019-04-11T01:13:43Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Recombination Based Part Assembly
Deming, Laura; Slusarczyk, Adrian; Jiao, Yunxin; iGEM, 2010 MIT
Here we propose a new recombination-based assembly standard, optimized to allow for efficient cloning of mammalian vectors.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Open licensing of BioBrick parts</title>
<link href="https://hdl.handle.net/1721.1/60081" rel="alternate"/>
<author>
<name>Lower, Michal</name>
</author>
<author>
<name>Olchowik, Anna</name>
</author>
<author>
<name>Pankowski, Jaroslaw</name>
</author>
<author>
<name>Bazlekowa, Milena</name>
</author>
<author>
<name>Blaszkiewicz, Marta</name>
</author>
<author>
<name>Cysewski, Dominik</name>
</author>
<author>
<name>Koper, Kamil</name>
</author>
<author>
<name>Lesczynska, Joanna</name>
</author>
<author>
<name>Moreno, Cherry</name>
</author>
<author>
<name>Pulawska, Anna</name>
</author>
<id>https://hdl.handle.net/1721.1/60081</id>
<updated>2019-04-11T01:13:53Z</updated>
<published>2010-12-05T00:00:00Z</published>
<summary type="text">Open licensing of BioBrick parts
Lower, Michal; Olchowik, Anna; Pankowski, Jaroslaw; Bazlekowa, Milena; Blaszkiewicz, Marta; Cysewski, Dominik; Koper, Kamil; Lesczynska, Joanna; Moreno, Cherry; Pulawska, Anna
This document provides recommendations for licensing of community-created biological parts, especially in BioBrick standard.
</summary>
<dc:date>2010-12-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>DTU Synthetic Promoter Library Standard</title>
<link href="https://hdl.handle.net/1721.1/60080" rel="alternate"/>
<author>
<name>Fortuna, Patrick</name>
</author>
<author>
<name>Trolle, Thomas</name>
</author>
<author>
<name>Borch, Martin Malthe</name>
</author>
<author>
<name>Haugaard, Anastasiya</name>
</author>
<author>
<name>Kjaergaard, Maya Friis</name>
</author>
<author>
<name>Iversen, Lisa Blanc</name>
</author>
<author>
<name>Jollmann, Annemi</name>
</author>
<author>
<name>Sander, Anja</name>
</author>
<author>
<name>Frederiksen, Juliet</name>
</author>
<author>
<name>Slodkowicz, Grzegorz</name>
</author>
<id>https://hdl.handle.net/1721.1/60080</id>
<updated>2019-04-11T01:13:52Z</updated>
<published>2010-12-04T00:00:00Z</published>
<summary type="text">DTU Synthetic Promoter Library Standard
Fortuna, Patrick; Trolle, Thomas; Borch, Martin Malthe; Haugaard, Anastasiya; Kjaergaard, Maya Friis; Iversen, Lisa Blanc; Jollmann, Annemi; Sander, Anja; Frederiksen, Juliet; Slodkowicz, Grzegorz
The purpose of this RFC is to outline a method for generating a BioBrick compatible Synthetic Promoter Library (SPL) within bacteria in order to fine-tune the expression of BioBrick parts and devices.
</summary>
<dc:date>2010-12-04T00:00:00Z</dc:date>
</entry>
<entry>
<title>Standard Biological Part Automatic Modeling  Database Language (MoDeL)</title>
<link href="https://hdl.handle.net/1721.1/59957" rel="alternate"/>
<author>
<name>Wang, Zhen</name>
</author>
<author>
<name>Liao, Chen</name>
</author>
<author>
<name>Jiang, Hao</name>
</author>
<author>
<name>Yao, Xiaomo</name>
</author>
<author>
<name>Jiang, Kun</name>
</author>
<id>https://hdl.handle.net/1721.1/59957</id>
<updated>2019-04-11T01:13:36Z</updated>
<published>2010-11-09T00:00:00Z</published>
<summary type="text">Standard Biological Part Automatic Modeling  Database Language (MoDeL)
Wang, Zhen; Liao, Chen; Jiang, Hao; Yao, Xiaomo; Jiang, Kun
This BioBricks Foundation Request for Comments (BBF RFC) describes the Standard Biological Part &#13;
Automatic Modeling Database Language (MoDeL). MoDeL provides a language and syntax standard &#13;
for automatic modeling databases used by synthetic biology software. Meanwhile, MoDeL allows &#13;
detailed description of biological complex, and presents the concept of Chain-Node Model.
</summary>
<dc:date>2010-11-09T00:00:00Z</dc:date>
</entry>
<entry>
<title>Promoter and Coding Sequence Considerations for Caenorhabditis elegans and Other Eukaryotes</title>
<link href="https://hdl.handle.net/1721.1/59851" rel="alternate"/>
<author>
<name>Palmer, Chris</name>
</author>
<author>
<name>Halliday, Geoff</name>
</author>
<id>https://hdl.handle.net/1721.1/59851</id>
<updated>2019-04-10T20:24:58Z</updated>
<published>2010-11-07T00:00:00Z</published>
<summary type="text">Promoter and Coding Sequence Considerations for Caenorhabditis elegans and Other Eukaryotes
Palmer, Chris; Halliday, Geoff
Our primary aim is to provide a standard format for protein-coding BioBricks intended for &#13;
eukaryotes, especially in the nematode worm Caenorhabditis elegans, so that future teams will be &#13;
able to correctly take advantage of the Kozak consensus sequence and its power to manipulate &#13;
gene expression levels. There are currently, in fact, at least three protein-coding BioBricks with &#13;
Kozak sequences that correctly conform to this convention, designed for yeast, &#13;
(BBa_K165057, BBa_K165058, and BBa_K165059) but their format has not been &#13;
documented or standardized. Since this is so important to full exploitation of current and future &#13;
eukaryotic chassis, we feel it must be codified.
</summary>
<dc:date>2010-11-07T00:00:00Z</dc:date>
</entry>
<entry>
<title>Fast multiple gene fragment ligation method based on homologous recombination</title>
<link href="https://hdl.handle.net/1721.1/59803" rel="alternate"/>
<author>
<name>Wang, Ruiyan</name>
</author>
<author>
<name>Shi, Zhenyu</name>
</author>
<author>
<name>Li, Teng</name>
</author>
<author>
<name>Chen, Guoqiang</name>
</author>
<id>https://hdl.handle.net/1721.1/59803</id>
<updated>2019-04-11T01:13:02Z</updated>
<published>2010-10-31T00:00:00Z</published>
<summary type="text">Fast multiple gene fragment ligation method based on homologous recombination
Wang, Ruiyan; Shi, Zhenyu; Li, Teng; Chen, Guoqiang
With the established BioBrick Assembly standards, ligation of different parts has to be accomplished step by step. It can be time-consuming when dealing with multiple fragment ligation. BBF RFC 62 is developed aimed at completing the ligation of multiple fragments quickly and efficiently based on homologous recombination.
</summary>
<dc:date>2010-10-31T00:00:00Z</dc:date>
</entry>
<entry>
<title>Fast multiple gene fragment ligation method based on Type IIs restriction enzyme DraIII</title>
<link href="https://hdl.handle.net/1721.1/59802" rel="alternate"/>
<author>
<name>Shi, Zhenyu</name>
</author>
<author>
<name>Li, Teng</name>
</author>
<author>
<name>Chen, Guoqiang</name>
</author>
<id>https://hdl.handle.net/1721.1/59802</id>
<updated>2019-04-12T11:35:51Z</updated>
<published>2010-10-31T00:00:00Z</published>
<summary type="text">Fast multiple gene fragment ligation method based on Type IIs restriction enzyme DraIII
Shi, Zhenyu; Li, Teng; Chen, Guoqiang
With the established BioBrick Assembly standards, ligation of different parts has to be accomplished step by step. It can be time-consuming when dealing with multiple fragment ligation. BBF RFC 61 is developed aimed at completing the ligation of multiple fragments quickly and efficiently based on Type II restriction enzyme DraIII.
</summary>
<dc:date>2010-10-31T00:00:00Z</dc:date>
</entry>
<entry>
<title>Quantitative measurement of mammalian cell invasion by bacteria using flow cytometry</title>
<link href="https://hdl.handle.net/1721.1/59801" rel="alternate"/>
<author>
<name>Lower, Michal</name>
</author>
<author>
<name>Olchowik, Anna</name>
</author>
<id>https://hdl.handle.net/1721.1/59801</id>
<updated>2019-04-11T01:13:01Z</updated>
<published>2010-10-31T00:00:00Z</published>
<summary type="text">Quantitative measurement of mammalian cell invasion by bacteria using flow cytometry
Lower, Michal; Olchowik, Anna
Purpose of this RFC is to provide method of measurement of bacterial invasion into mammalian cells. Also this RFC defines Percent of INvasion (PIN) unit.
</summary>
<dc:date>2010-10-31T00:00:00Z</dc:date>
</entry>
<entry>
<title>Abbreviated BioBrick Prefix and Suffix for More Efficient Primer Design</title>
<link href="https://hdl.handle.net/1721.1/59800" rel="alternate"/>
<author>
<name>Thing, Teoh Shao</name>
</author>
<author>
<name>Yasumoto, Shuhei</name>
</author>
<author>
<name>Nakamura, Tadashi</name>
</author>
<author>
<name>Saka, Takahiro</name>
</author>
<author>
<name>Torigata, Kousuke</name>
</author>
<author>
<name>Rie, Takino</name>
</author>
<author>
<name>Kakuda, Saya</name>
</author>
<author>
<name>Youfeng, Lin</name>
</author>
<author>
<name>Otake, Toshiyuki</name>
</author>
<author>
<name>Miyatake, Yuki</name>
</author>
<author>
<name>Ikumi, Hirayama</name>
</author>
<author>
<name>Kagaya, Takuro A.</name>
</author>
<author>
<name>Ono, Naoaki</name>
</author>
<author>
<name>Stewart, Donal</name>
</author>
<author>
<name>Wilson-Kanamori, John Roger</name>
</author>
<author>
<name>Lu, Meng</name>
</author>
<author>
<name>Rostain, William</name>
</author>
<author>
<name>Kowal, Maria</name>
</author>
<author>
<name>Partridge-Hicks, Richard</name>
</author>
<author>
<name>Hunt, Sarah</name>
</author>
<author>
<name>Bereska, Marta</name>
</author>
<author>
<name>Fraser, Hannah</name>
</author>
<author>
<name>Coombes, Matthew</name>
</author>
<author>
<name>Barnard, Damian</name>
</author>
<author>
<name>Elfick, Alistair</name>
</author>
<author>
<name>French, Chris</name>
</author>
<id>https://hdl.handle.net/1721.1/59800</id>
<updated>2019-04-11T10:15:28Z</updated>
<published>2010-10-31T00:00:00Z</published>
<summary type="text">Abbreviated BioBrick Prefix and Suffix for More Efficient Primer Design
Thing, Teoh Shao; Yasumoto, Shuhei; Nakamura, Tadashi; Saka, Takahiro; Torigata, Kousuke; Rie, Takino; Kakuda, Saya; Youfeng, Lin; Otake, Toshiyuki; Miyatake, Yuki; Ikumi, Hirayama; Kagaya, Takuro A.; Ono, Naoaki; Stewart, Donal; Wilson-Kanamori, John Roger; Lu, Meng; Rostain, William; Kowal, Maria; Partridge-Hicks, Richard; Hunt, Sarah; Bereska, Marta; Fraser, Hannah; Coombes, Matthew; Barnard, Damian; Elfick, Alistair; French, Chris
This Request for Comments (RFC) modifies the assembly standard for biological parts proposed in BBF RFC 10 by removing the NotI restriction site from the BioBrick Prefix and Suffix.
</summary>
<dc:date>2010-10-31T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 56: “Part Flavors” For Peptide-Coding Parts</title>
<link href="https://hdl.handle.net/1721.1/59011" rel="alternate"/>
<author>
<name>Anderson, J. Chris</name>
</author>
<id>https://hdl.handle.net/1721.1/59011</id>
<updated>2019-04-13T00:09:46Z</updated>
<published>2010-10-11T00:00:00Z</published>
<summary type="text">BBF RFC 56: “Part Flavors” For Peptide-Coding Parts
Anderson, J. Chris
“Part Flavors” are a means of describing the grammatical properties of parts.  Specifically, this is introduced as a means of describing parts that encode peptides (CDS parts), but there may be value to extrapolating the concept to other types of parts.  A CDS part flavor is intended to address the problem of how to precisely describe compositions of parts that differ by the presence of 5’ and 3’ spacers, presence or absence of start codons, stop codons, and ribosome binding sites, etc.  The goal is to be able to describe these in such a way that grammar-based software tools (such as Genocad or Eugene) could register the grammatical equivalence of two parts.  This facilitates automated design strategies in which an abstract device (such as promoter.rbs.CDS.terminator) can be instantiated to grammatically correct compositions (such as r0040.b0034.E0040.b0015).  The concept is an extension of RFC 13 which proposes to describe CDS parts as “head,” “internal,” “special,” or “tail” domains.  The difference is a little subtle, it has nothing to do with what the part encodes per se, but rather seeks to distinguish the translation-related properties of the encoded part and separate them into grammatically-equivalent categories, and in so doing allows for there being more “flavors” of part that can exist (and already do exist).  &#13;
I describe the concept here since we’ve been using this concept for the past 2 years or so, and there are already a number of parts whose descriptions are written with the flavor notations described herein in the Registry.  This document serves as a guide to interpreting the codes.  This may also be of value to others as a means of distinguishing their different types of parts.
</summary>
<dc:date>2010-10-11T00:00:00Z</dc:date>
</entry>
<entry>
<title>The BioBrick Public Agreement v1a</title>
<link href="https://hdl.handle.net/1721.1/50999" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Grewal, David</name>
</author>
<author>
<name>Schultz, Jason</name>
</author>
<author>
<name>Lynch, Jennifer</name>
</author>
<author>
<name>Crews, Lee</name>
</author>
<author>
<name>Fischer, Mark</name>
</author>
<id>https://hdl.handle.net/1721.1/50999</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2010-01-25T16:29:55Z</published>
<summary type="text">The BioBrick Public Agreement v1a
Endy, Drew; Grewal, David; Schultz, Jason; Lynch, Jennifer; Crews, Lee; Fischer, Mark
We present an updated, clean draft for additional public comment of a new legal framework supporting the future of biotechnology. The framework, named here as the BioBrick Public Agreement, is based upon the contribution of promises not to assert any property rights against users of so-contributed standard biological parts. Comments and feedback on this working draft are requested.  This draft, BPA v1a, replaces and earlier draft, BPA v1.
</summary>
<dc:date>2010-01-25T16:29:55Z</dc:date>
</entry>
<entry>
<title>BBF RFC 16: Synthetic Biology Open Language Visual (SBOLv) Specification</title>
<link href="https://hdl.handle.net/1721.1/49523" rel="alternate"/>
<author>
<name>Rodriguez, Cesar</name>
</author>
<author>
<name>Bartram, Suzie</name>
</author>
<author>
<name>Ramasubramanian, Anusuya</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/49523</id>
<updated>2019-04-12T23:25:26Z</updated>
<published>2009-11-01T19:39:55Z</published>
<summary type="text">BBF RFC 16: Synthetic Biology Open Language Visual (SBOLv) Specification
Rodriguez, Cesar; Bartram, Suzie; Ramasubramanian, Anusuya; Endy, Drew
Synthetic Biology Open Language Visual (SBOLv) is a graphical notation that supports &#13;
biological device development. It provides a formal notation for describing the physical &#13;
composition of basic parts into composite parts during the development of biological devices. It &#13;
is targeted for use by biological engineers in forward engineering projects. It encourages and &#13;
supports model-driven engineering.
</summary>
<dc:date>2009-11-01T19:39:55Z</dc:date>
</entry>
<entry>
<title>The USER cloning standard</title>
<link href="https://hdl.handle.net/1721.1/49522" rel="alternate"/>
<author>
<name>Kaas, Christian Schrøder</name>
</author>
<author>
<name>Hansen, Niels Bjørn</name>
</author>
<author>
<name>Genee, Hans Jasper</name>
</author>
<author>
<name>Olsen, Lars Rønn</name>
</author>
<author>
<name>Matos, Cláudia</name>
</author>
<author>
<name>Bonde, Mads Tvillinggaard</name>
</author>
<author>
<name>Hansen, Bjarne Gram</name>
</author>
<id>https://hdl.handle.net/1721.1/49522</id>
<updated>2019-04-12T23:25:26Z</updated>
<published>2009-11-01T18:17:28Z</published>
<summary type="text">The USER cloning standard
Kaas, Christian Schrøder; Hansen, Niels Bjørn; Genee, Hans Jasper; Olsen, Lars Rønn; Matos, Cláudia; Bonde, Mads Tvillinggaard; Hansen, Bjarne Gram
This BioBricks Foundation Request for Comments (BBF RFC) provides information about the design of uracil-containing primers used for USER cloning and USER fusion.
</summary>
<dc:date>2009-11-01T18:17:28Z</dc:date>
</entry>
<entry>
<title>Large-Scale Peptide Modification on BioBrick Proteins</title>
<link href="https://hdl.handle.net/1721.1/49521" rel="alternate"/>
<author>
<name>Tian, Feng</name>
</author>
<author>
<name>Chen, GuoQiang</name>
</author>
<author>
<name>Wang, Zhao</name>
</author>
<id>https://hdl.handle.net/1721.1/49521</id>
<updated>2019-04-12T23:25:25Z</updated>
<published>2009-10-30T22:12:05Z</published>
<summary type="text">Large-Scale Peptide Modification on BioBrick Proteins
Tian, Feng; Chen, GuoQiang; Wang, Zhao
With the established BioBrick Assembly standards, fusion proteins with diversified&#13;
functions are easy to manipulate. However, we realized that the existing BBF RFC do not&#13;
clearly defining the standard for peptide display on BioBrick proteins. Considering the&#13;
promising use of specific small peptide modification on functional proteins, targeting to&#13;
specific cell types, for example, we proposed a standard for small peptide modification&#13;
on BioBrick proteins.
</summary>
<dc:date>2009-10-30T22:12:05Z</dc:date>
</entry>
<entry>
<title>Design of Specific Mammalian Promoters by in silico Prediction</title>
<link href="https://hdl.handle.net/1721.1/49520" rel="alternate"/>
<author>
<name>Heinemann, Tim</name>
</author>
<author>
<name>Kramer, Stephen</name>
</author>
<author>
<name>Velten, Lars</name>
</author>
<author>
<name>Kranz, Anna-Lena</name>
</author>
<author>
<name>Bauer, Tobias</name>
</author>
<author>
<name>Faura, Marti Bernardo</name>
</author>
<author>
<name>Konig, Rainer</name>
</author>
<author>
<name>Keienburg, Jens</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<author>
<name>Iwamoto, Nao</name>
</author>
<id>https://hdl.handle.net/1721.1/49520</id>
<updated>2019-04-09T18:50:08Z</updated>
<published>2009-10-30T22:02:45Z</published>
<summary type="text">Design of Specific Mammalian Promoters by in silico Prediction
Heinemann, Tim; Kramer, Stephen; Velten, Lars; Kranz, Anna-Lena; Bauer, Tobias; Faura, Marti Bernardo; Konig, Rainer; Keienburg, Jens; Eils, Roland; Iwamoto, Nao
The purpose of this RFC is to provide a) a method for the design of rational&#13;
synthetic promoter sequences based on a statistical analysis about&#13;
the spatial preference of transcription factor binding sites in human promoter sequences and b) further introduce standards to provide compatibility&#13;
with data formats introduced in this RFC. Description of promoters generated by this method can be found at http://2009.igem.org/Team:Heidelberg/HEARTBEAT_database.
</summary>
<dc:date>2009-10-30T22:02:45Z</dc:date>
</entry>
<entry>
<title>BBF RFC 47: BioBytes Assembly Standard</title>
<link href="https://hdl.handle.net/1721.1/49518" rel="alternate"/>
<author>
<name>Ellison, Michael</name>
</author>
<author>
<name>Ridgway, Doug</name>
</author>
<author>
<name>Fedor, Justin</name>
</author>
<author>
<name>Garside, Erin</name>
</author>
<author>
<name>Robinson, Kelly</name>
</author>
<author>
<name>Lloyd, David</name>
</author>
<id>https://hdl.handle.net/1721.1/49518</id>
<updated>2019-04-12T23:25:25Z</updated>
<published>2009-10-29T23:42:34Z</published>
<summary type="text">BBF RFC 47: BioBytes Assembly Standard
Ellison, Michael; Ridgway, Doug; Fedor, Justin; Garside, Erin; Robinson, Kelly; Lloyd, David
The BioBytes assembly method provides a new high-throughput way of assembling &#13;
plasmids as well as other large DNA constructs.  Using a bead-linked assembly of genetic &#13;
parts with long (12 bp) standardized sticky ends, it allows for greater speed and &#13;
efficiency in assembling these components.  This document defines a standard for genetic &#13;
parts compatible with the assembly system and describes detailed protocols for the &#13;
construction of such parts and their rapid assembly. Although the original motivation for &#13;
the method was to produce whole synthetic genomes, the design allows for any type of &#13;
DNA construction.
</summary>
<dc:date>2009-10-29T23:42:34Z</dc:date>
</entry>
<entry>
<title>Bioscaffold-Linker</title>
<link href="https://hdl.handle.net/1721.1/49505" rel="alternate"/>
<author>
<name>Mina, Petros</name>
</author>
<author>
<name>Savery, Nigel</name>
</author>
<id>https://hdl.handle.net/1721.1/49505</id>
<updated>2019-04-09T18:46:20Z</updated>
<published>2009-10-21T02:36:41Z</published>
<summary type="text">Bioscaffold-Linker
Mina, Petros; Savery, Nigel
Protein fusions are currently not supported by most assembly standards. This assembly standard aims to provide the basis of a solution to a biobrick-friendly protein fusion mechanism that supports the current favorite assembly standard 10 (RFC10) and hence allows utilization of most of the current biobricks database.
</summary>
<dc:date>2009-10-21T02:36:41Z</dc:date>
</entry>
<entry>
<title>How to Build Kinetic Models of BioBricks</title>
<link href="https://hdl.handle.net/1721.1/49504" rel="alternate"/>
<author>
<name>Weeding, Emma</name>
</author>
<author>
<name>Houle, Jason</name>
</author>
<author>
<name>Swiniarski, Ben</name>
</author>
<author>
<name>Smadbeck, Patrick</name>
</author>
<author>
<name>Lindblad, Kristen</name>
</author>
<author>
<name>Volzing, Katherine</name>
</author>
<author>
<name>Srivastava, Poonam</name>
</author>
<author>
<name>Sotiropoulos, Vassilios</name>
</author>
<author>
<name>Biliouris, Kostas</name>
</author>
<author>
<name>Kaznessis, Yiannis</name>
</author>
<id>https://hdl.handle.net/1721.1/49504</id>
<updated>2019-04-09T16:42:31Z</updated>
<published>2009-10-21T02:07:22Z</published>
<summary type="text">How to Build Kinetic Models of BioBricks
Weeding, Emma; Houle, Jason; Swiniarski, Ben; Smadbeck, Patrick; Lindblad, Kristen; Volzing, Katherine; Srivastava, Poonam; Sotiropoulos, Vassilios; Biliouris, Kostas; Kaznessis, Yiannis
This BioBricks Foundation Request for Comments (BBF RFC) provides instructions on how to automatically generate a model of any BioBrick sequence. These models can be used in computer simulations of the dynamic behavior of all molecular components of the BioBrick.
</summary>
<dc:date>2009-10-21T02:07:22Z</dc:date>
</entry>
<entry>
<title>Cloning Standard for Mammalian BioBrick Parts and Devices</title>
<link href="https://hdl.handle.net/1721.1/49503" rel="alternate"/>
<author>
<name>Bartoschek, Michael</name>
</author>
<author>
<name>Mugahid, Douaa</name>
</author>
<author>
<name>Rademacher, Anne</name>
</author>
<author>
<name>Meyer, Hannah</name>
</author>
<author>
<name>Velten, Lars</name>
</author>
<author>
<name>Reis, Yara</name>
</author>
<author>
<name>Keienburg, Jens</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/49503</id>
<updated>2019-04-10T07:38:59Z</updated>
<published>2009-10-21T01:45:14Z</published>
<summary type="text">Cloning Standard for Mammalian BioBrick Parts and Devices
Bartoschek, Michael; Mugahid, Douaa; Rademacher, Anne; Meyer, Hannah; Velten, Lars; Reis, Yara; Keienburg, Jens; Eils, Roland
To introduce a common cloning standard for BioBrick parts that find application in mammalian cells.
</summary>
<dc:date>2009-10-21T01:45:14Z</dc:date>
</entry>
<entry>
<title>RA-PCR, a method for the generation of randomized promoter libraries</title>
<link href="https://hdl.handle.net/1721.1/49502" rel="alternate"/>
<author>
<name>Velten, Lars</name>
</author>
<author>
<name>Haas, Simon</name>
</author>
<author>
<name>Rademacher, Anne</name>
</author>
<author>
<name>Meyer, Hannah</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/49502</id>
<updated>2019-04-10T07:38:59Z</updated>
<published>2009-10-21T01:24:36Z</published>
<summary type="text">RA-PCR, a method for the generation of randomized promoter libraries
Velten, Lars; Haas, Simon; Rademacher, Anne; Meyer, Hannah; Eils, Roland
The purpose of this RFC is to provide instructions for the synthesis of promoters in mammalian cells that are active at a desired cellular condition (where a cellular condition is specified by the activity of a set of transcription factors of interest). The method generates a library of promoters putatively active under the desired condition. This RFC also provides instructions on how to screen the libraries generated by this method in order to obtain functional promoters. Description of promoters generated by this method can be found at http://2009.igem.org/Team:Heidelberg/Project_Synthetic_promoters.
</summary>
<dc:date>2009-10-21T01:24:36Z</dc:date>
</entry>
<entry>
<title>Units for Promoter Measurement in Mammalian Cells</title>
<link href="https://hdl.handle.net/1721.1/49501" rel="alternate"/>
<author>
<name>Velten, Lars</name>
</author>
<author>
<name>Iwamoto, Nao</name>
</author>
<author>
<name>Hiller, Corinna</name>
</author>
<author>
<name>Uckelmann, Hannah</name>
</author>
<author>
<name>Zhu, Chenchen</name>
</author>
<author>
<name>Zhao, Bingqing</name>
</author>
<author>
<name>Richter, Daniela</name>
</author>
<author>
<name>Hundeshagen, Phillip</name>
</author>
<author>
<name>Reichenzeller, Michaela</name>
</author>
<author>
<name>Keienburg, Jens</name>
</author>
<author>
<name>Eils, Roland</name>
</author>
<id>https://hdl.handle.net/1721.1/49501</id>
<updated>2019-04-12T23:25:17Z</updated>
<published>2009-10-21T01:18:06Z</published>
<summary type="text">Units for Promoter Measurement in Mammalian Cells
Velten, Lars; Iwamoto, Nao; Hiller, Corinna; Uckelmann, Hannah; Zhu, Chenchen; Zhao, Bingqing; Richter, Daniela; Hundeshagen, Phillip; Reichenzeller, Michaela; Keienburg, Jens; Eils, Roland
The purpose of this RFC is to provide units for the characterization of promoter strength for use in mammalian cells. RMPU is mRNA based and&#13;
directly proportional to PoPS, whereas REU is protein based and not proportional to PoPS.
</summary>
<dc:date>2009-10-21T01:18:06Z</dc:date>
</entry>
<entry>
<title>The BioBrick Public Agreement v1 (draft)</title>
<link href="https://hdl.handle.net/1721.1/49434" rel="alternate"/>
<author>
<name>Fischer, Mark</name>
</author>
<author>
<name>Crews, Lee</name>
</author>
<author>
<name>Lynch, Jennifer</name>
</author>
<author>
<name>Schultz, Jason</name>
</author>
<author>
<name>Grewal, David</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/49434</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2009-10-18T14:13:45Z</published>
<summary type="text">The BioBrick Public Agreement v1 (draft)
Fischer, Mark; Crews, Lee; Lynch, Jennifer; Schultz, Jason; Grewal, David; Endy, Drew
We present a draft for public comment of a new legal framework supporting the future of biotechnology.  The framework, named here as the BioBrick Public Agreement, is based upon the contribution of promises not to assert any property rights against users of so-contributed standard biological parts.  Comments and feedback on this working draft are requested.
</summary>
<dc:date>2009-10-18T14:13:45Z</dc:date>
</entry>
<entry>
<title>BBF RFC 38: RFC 38: Building Blocks - Standard Large DNA/Genome Construction</title>
<link href="https://hdl.handle.net/1721.1/49417" rel="alternate"/>
<author>
<name>DiCarlo, James</name>
</author>
<author>
<name>Boeke, Jef</name>
</author>
<id>https://hdl.handle.net/1721.1/49417</id>
<updated>2019-04-12T23:25:14Z</updated>
<published>2009-10-07T21:51:51Z</published>
<summary type="text">BBF RFC 38: RFC 38: Building Blocks - Standard Large DNA/Genome Construction
DiCarlo, James; Boeke, Jef
The physical assembly of standard parts is currently a non-standard process, which can either &#13;
come from direct genome PCR with restriction enzyme sites incorporated into the PCR primers, &#13;
or overlap assembly PCR. Furthermore, current Biobrick construction standards [RFC 10,11,12 &#13;
etc.] rely heavily on restriction enzyme based methods, which can be sequence, cost and time &#13;
restrictive. This is especially true of large DNA assembly, where 100% control of over DNA &#13;
sequence may be mandatory, such as in whole genome assembly. We propose a novel standard, &#13;
The Building Block Method, for both the construction of standard parts and their assembly &#13;
This Building Block standard can be either A) an interchangeable or B) a non-interchangeable &#13;
format, based on the desired use of the part.
</summary>
<dc:date>2009-10-07T21:51:51Z</dc:date>
</entry>
<entry>
<title>BBF RFC 21: BglBricks Assembly Standard</title>
<link href="https://hdl.handle.net/1721.1/46747" rel="alternate"/>
<author>
<name>Anderson, J Christopher</name>
</author>
<author>
<name>Dueber, John E</name>
</author>
<author>
<name>Leguia, Mariana</name>
</author>
<author>
<name>Wu, Gabriel C</name>
</author>
<author>
<name>Goler, Jonathan A</name>
</author>
<author>
<name>Arkin, Adam P</name>
</author>
<author>
<name>Keasling, Jay D</name>
</author>
<id>https://hdl.handle.net/1721.1/46747</id>
<updated>2019-04-10T11:56:07Z</updated>
<published>2009-09-18T14:38:40Z</published>
<summary type="text">BBF RFC 21: BglBricks Assembly Standard
Anderson, J Christopher; Dueber, John E; Leguia, Mariana; Wu, Gabriel C; Goler, Jonathan A; Arkin, Adam P; Keasling, Jay D
The BglBricks standard has been developed as an alternative to the original XbaI/SpeI standard primarily to provide a solution to the issue of generating translational-fusion parts. When joined together in a standard assembly reaction, BglBricks parts contain a scar sequence of GGATCT between the two parts. This sequence conveniently translates as Gly-Ser in the zero frame, a commonly-used linker in protein engineering. BglBricks has previously been called the “BglBrick” standard, and is also referred to as Assembly standard 21. A consolidated description of the standard is available at: http://openwetware.org/wiki/Template:AndersonLab:BglBrick_Standard
</summary>
<dc:date>2009-09-18T14:38:40Z</dc:date>
</entry>
<entry>
<title>BBF RFC 28: A method for combinatorial multi-part assembly based on the Type IIs restriction enzyme AarI</title>
<link href="https://hdl.handle.net/1721.1/46721" rel="alternate"/>
<author>
<name>Peisajovich, Sergio G.</name>
</author>
<author>
<name>Horwitz, Andrew</name>
</author>
<author>
<name>Hoeller, Oliver</name>
</author>
<author>
<name>Rhau, Benjamin</name>
</author>
<author>
<name>Lim, Wendell</name>
</author>
<id>https://hdl.handle.net/1721.1/46721</id>
<updated>2019-04-12T10:03:53Z</updated>
<published>2009-09-16T14:12:33Z</published>
<summary type="text">BBF RFC 28: A method for combinatorial multi-part assembly based on the Type IIs restriction enzyme AarI
Peisajovich, Sergio G.; Horwitz, Andrew; Hoeller, Oliver; Rhau, Benjamin; Lim, Wendell
This BioBricks Foundation Request for Comments (BBF RFC) describes an alternative&#13;
assembly standard based on the Type IIS restriction enzyme AarI.
</summary>
<dc:date>2009-09-16T14:12:33Z</dc:date>
</entry>
<entry>
<title>BBF RFC 37: Fusion protein BioBrick assembly standard with optional linker extension</title>
<link href="https://hdl.handle.net/1721.1/46705" rel="alternate"/>
<author>
<name>Bencina, Mojca</name>
</author>
<author>
<name>Jerala, Roman</name>
</author>
<id>https://hdl.handle.net/1721.1/46705</id>
<updated>2019-04-11T00:37:03Z</updated>
<published>2009-09-02T17:09:25Z</published>
<summary type="text">BBF RFC 37: Fusion protein BioBrick assembly standard with optional linker extension
Bencina, Mojca; Jerala, Roman
This RFC 37 describes an extension of the original BioBrick assembly standard (BBF RFC&#13;
10) and Freiburg assembly standard (BBF RFC 25). The Fusion Assembly strategy described&#13;
here is fully compatible with RFC 25 (Freiburg) and RFC 10 standard and supports in-frame&#13;
fusion and controlled potentially infinite extension of linker between protein fusion domains.
BBF RFC 37 replaces BBF RFC 36.
</summary>
<dc:date>2009-09-02T17:09:25Z</dc:date>
</entry>
<entry>
<title>BBF RFC 36: Fusion protein BioBrick assembly standard with optional linker extension</title>
<link href="https://hdl.handle.net/1721.1/46701" rel="alternate"/>
<author>
<name>Jerala, Roman</name>
</author>
<id>https://hdl.handle.net/1721.1/46701</id>
<updated>2019-04-11T00:37:02Z</updated>
<published>2009-09-01T16:15:53Z</published>
<summary type="text">BBF RFC 36: Fusion protein BioBrick assembly standard with optional linker extension
Jerala, Roman
This RFC 36 describes an extension of the original BioBrick assembly standard (BBF RFC 10) and Freiburg assembly standard (BBF RFC 25). The Fusion Assembly strategy described here is fully compatible with RFC 25 (Freiburg) and RFC 10 standard and supports in-frame fusion and controlled potentially infinite extension of linker between protein fusion domains.
</summary>
<dc:date>2009-09-01T16:15:53Z</dc:date>
</entry>
<entry>
<title>Raw Data, Win MN, Smolke CD. 2008. Higher-order cellular information processing with synthetic  RNA devices. Science. 322: 456-60. DOI: 10.1126/science.1160311</title>
<link href="https://hdl.handle.net/1721.1/46338" rel="alternate"/>
<author>
<name>Win, Maung Nyan</name>
</author>
<author>
<name>Smolke, Christina</name>
</author>
<id>https://hdl.handle.net/1721.1/46338</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2009-07-29T06:23:51Z</published>
<summary type="text">Raw Data, Win MN, Smolke CD. 2008. Higher-order cellular information processing with synthetic  RNA devices. Science. 322: 456-60. DOI: 10.1126/science.1160311
Win, Maung Nyan; Smolke, Christina
This supplement provides additional detail on the data analysis methods and the raw data for the &#13;
RNA devices presented in the published manuscript and supporting online material. The &#13;
information provided in the current supplement is organized as follows: &#13;
 &#13;
1.  Gating methods for the raw flow cytometry data &#13;
2.  Correction methods for nonspecific effects on fluorescence of chemical effectors &#13;
controlling the RNA devices &#13;
3.  Selection of standard against which to report device performance &#13;
4.  Relevance to conclusions published in the Science paper &#13;
5. Example calculations &#13;
6.  Raw data for RNA devices
</summary>
<dc:date>2009-07-29T06:23:51Z</dc:date>
</entry>
<entry>
<title>Adventures in Synthetic Biology</title>
<link href="https://hdl.handle.net/1721.1/46337" rel="alternate"/>
<author>
<name>Wadey, Chuck</name>
</author>
<author>
<name>Deese, Isadora</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/46337</id>
<updated>2025-02-27T21:04:34Z</updated>
<published>2005-11-24T00:00:00Z</published>
<summary type="text">Adventures in Synthetic Biology
Wadey, Chuck; Deese, Isadora; Endy, Drew
3 chapter comic book reflecting the early engineering period of synthetic biology ~2005.  Translations freely available by searching online.
</summary>
<dc:date>2005-11-24T00:00:00Z</dc:date>
</entry>
<entry>
<title>BBF RFC 26: In-Fusion BioBrick Assembly</title>
<link href="https://hdl.handle.net/1721.1/46328" rel="alternate"/>
<author>
<name>Sleight, Sean</name>
</author>
<id>https://hdl.handle.net/1721.1/46328</id>
<updated>2019-04-12T10:01:35Z</updated>
<published>2009-07-09T18:53:13Z</published>
<summary type="text">BBF RFC 26: In-Fusion BioBrick Assembly
Sleight, Sean
This BioBricks Foundation Request for Comments (BBF RFC) describes a method to &#13;
assemble two BioBricks using the Clontech In-Fusion PCR Cloning Kit while maintaining &#13;
BioBrick standard formats.
</summary>
<dc:date>2009-07-09T18:53:13Z</dc:date>
</entry>
<entry>
<title>Advance Online Correction to PNAS v104 p14283</title>
<link href="https://hdl.handle.net/1721.1/45668" rel="alternate"/>
<author>
<name>Smolke, CD</name>
</author>
<author>
<name>Win, MN</name>
</author>
<id>https://hdl.handle.net/1721.1/45668</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2009-06-30T06:48:12Z</published>
<summary type="text">Advance Online Correction to PNAS v104 p14283
Smolke, CD; Win, MN
We are publishing the following draft correction and clarification to Proc Natl Acad Sci U S A. &#13;
2007 Sep 4;104(36):14283-8. We are now working directly with the PNAS Editor to have this &#13;
correction published by the journal as well.
Early publication of correction and clarification to referenced article in PNAS USA.
</summary>
<dc:date>2009-06-30T06:48:12Z</dc:date>
</entry>
<entry>
<title>Provisional BioBrick Language (PoBoL)</title>
<link href="https://hdl.handle.net/1721.1/45537" rel="alternate"/>
<author>
<name>Galdzicki, Michal</name>
</author>
<author>
<name>Chandran, Deepak</name>
</author>
<author>
<name>Nielsen, Alec</name>
</author>
<author>
<name>Morrison, Jason</name>
</author>
<author>
<name>Cowell, Mackenzie</name>
</author>
<author>
<name>Grünberg, Raik</name>
</author>
<author>
<name>Sleight, Sean</name>
</author>
<author>
<name>Sauro, Herbert</name>
</author>
<id>https://hdl.handle.net/1721.1/45537</id>
<updated>2019-04-11T00:32:19Z</updated>
<published>2009-05-15T18:05:32Z</published>
<summary type="text">Provisional BioBrick Language (PoBoL)
Galdzicki, Michal; Chandran, Deepak; Nielsen, Alec; Morrison, Jason; Cowell, Mackenzie; Grünberg, Raik; Sleight, Sean; Sauro, Herbert
This BioBricks Foundation Request for Comments (BBF RFC) describes a semantic markup language for publishing and sharing information about BioBricks on the World Wide Web.&#13;
This BBF RFC includes the recommendation for the minimal information expected when&#13;
creating a Provisional BioBrick Language (PoBoL) description of BioBricks and for the implementation of the language using Web Ontology Language (OWL).
</summary>
<dc:date>2009-05-15T18:05:32Z</dc:date>
</entry>
<entry>
<title>BBF RFC 30: Draft of an RDF-based framework for  the exchange and integration of Synthetic Biology data</title>
<link href="https://hdl.handle.net/1721.1/45143" rel="alternate"/>
<author>
<name>Grunberg, Raik</name>
</author>
<id>https://hdl.handle.net/1721.1/45143</id>
<updated>2019-04-12T09:56:23Z</updated>
<published>2009-04-24T22:16:06Z</published>
<summary type="text">BBF RFC 30: Draft of an RDF-based framework for  the exchange and integration of Synthetic Biology data
Grunberg, Raik
This Request for Comments (RFC) suggests a framework for the description, &#13;
exchange and interlinking of Synthetic Biology data. The framework would &#13;
create an open process for the evolution and “rolling” standardization of data &#13;
models. It describes how data and data models are to be published, how they &#13;
are exchanged and integrated between diﬀerent parties, and how they can be &#13;
extended, corrected and interlinked in a decentralized fashion. These goals &#13;
are achieved by embracing the RDF (Resource Description Framework), a set &#13;
of W3C standards. A one-sentence summary of this proposal would there- &#13;
fore be: “Use RDF according to the W3C standards.” The PoBoL pro ject &#13;
(Provisional BioBrick Ontology Language, http://pobol.org) is based on &#13;
this idea. &#13;
This RFC does not describe a data model per se but only outlines a &#13;
possible architecture and rules of data exchange.
</summary>
<dc:date>2009-04-24T22:16:06Z</dc:date>
</entry>
<entry>
<title>Fusion Protein (Freiburg) Biobrick assembly standard</title>
<link href="https://hdl.handle.net/1721.1/45140" rel="alternate"/>
<author>
<name>Grünberg, Raik</name>
</author>
<author>
<name>Arndt, Katja</name>
</author>
<author>
<name>Müller, Kristian</name>
</author>
<id>https://hdl.handle.net/1721.1/45140</id>
<updated>2019-04-10T14:52:31Z</updated>
<published>2009-04-18T22:42:57Z</published>
<summary type="text">Fusion Protein (Freiburg) Biobrick assembly standard
Grünberg, Raik; Arndt, Katja; Müller, Kristian
This Request for Comments (RFC) describes an extension to the original BioBrick &#13;
assembly standard (BBF RFC 10). The Fusion Assembly strategy described here is fully &#13;
backwards compatible with RFC 10 and supports the construction of in frame fusion &#13;
proteins.
</summary>
<dc:date>2009-04-18T22:42:57Z</dc:date>
</entry>
<entry>
<title>Draft Standard for Biobrick BB-2 Biological Parts</title>
<link href="https://hdl.handle.net/1721.1/45139" rel="alternate"/>
<author>
<name>Knight, Tom</name>
</author>
<id>https://hdl.handle.net/1721.1/45139</id>
<updated>2019-04-05T18:57:54Z</updated>
<published>2008-11-19T00:00:00Z</published>
<summary type="text">Draft Standard for Biobrick BB-2 Biological Parts
Knight, Tom
This standard defines the required sequence properties for a&#13;
Biobrick(R) BB-2 standard biological part.  It does not define any&#13;
functional characteristics of the parts, nor does it motivate any&#13;
aspect of these standards.
</summary>
<dc:date>2008-11-19T00:00:00Z</dc:date>
</entry>
<entry>
<title>Draft Standard for Biobrick Biological Parts</title>
<link href="https://hdl.handle.net/1721.1/45138" rel="alternate"/>
<author>
<name>Knight, Tom</name>
</author>
<id>https://hdl.handle.net/1721.1/45138</id>
<updated>2019-04-07T05:17:05Z</updated>
<published>2007-05-03T00:00:00Z</published>
<summary type="text">Draft Standard for Biobrick Biological Parts
Knight, Tom
This standard defines the required sequence properties for a&#13;
Biobrick(tm) standard biological part.  It does not define any&#13;
functional characteristics of the parts, nor does it motivate any&#13;
aspect of these standards.  All sequences defined herein are specified&#13;
in the 5' to 3' direction.
</summary>
<dc:date>2007-05-03T00:00:00Z</dc:date>
</entry>
<entry>
<title>Naming of standards of physical  composition of BioBrick parts</title>
<link href="https://hdl.handle.net/1721.1/45137" rel="alternate"/>
<author>
<name>Rettberg, Randy</name>
</author>
<author>
<name>Shetty, Reshma</name>
</author>
<id>https://hdl.handle.net/1721.1/45137</id>
<updated>2019-04-09T19:18:35Z</updated>
<published>2009-04-17T21:23:35Z</published>
<summary type="text">Naming of standards of physical  composition of BioBrick parts
Rettberg, Randy; Shetty, Reshma
This BioBricks Foundation Request for Comments (BBF RFC) proposes a &#13;
naming convention for standards of physical composition of BioBrick parts &#13;
in which assembly standards are named according to the BBF RFC that &#13;
speciﬁes the standard.
</summary>
<dc:date>2009-04-17T21:23:35Z</dc:date>
</entry>
<entry>
<title>Constraint Relaxation of RFC 10 for Assembling Standard Biological Parts</title>
<link href="https://hdl.handle.net/1721.1/44962" rel="alternate"/>
<author>
<name>Che, Austin</name>
</author>
<id>https://hdl.handle.net/1721.1/44962</id>
<updated>2019-04-12T09:55:33Z</updated>
<published>2009-03-30T22:29:13Z</published>
<summary type="text">Constraint Relaxation of RFC 10 for Assembling Standard Biological Parts
Che, Austin
This Request for Comments (RFC) modifies the assembly standard for biological parts proposed in BBF RFC 10 by replacing PstI with SbfI and&#13;
dropping other sequence constraints. This change relaxes the constraints on&#13;
the part sequence while maintaining compatibility with existing parts that&#13;
use RFC 10.
</summary>
<dc:date>2009-03-30T22:29:13Z</dc:date>
</entry>
<entry>
<title>Conversion of Freiburg (Fusion) Biobricks to the Silver (BioFusion) format</title>
<link href="https://hdl.handle.net/1721.1/44961" rel="alternate"/>
<author>
<name>Grunberg, Raik</name>
</author>
<id>https://hdl.handle.net/1721.1/44961</id>
<updated>2019-04-10T11:14:08Z</updated>
<published>2009-03-30T18:33:51Z</published>
<summary type="text">Conversion of Freiburg (Fusion) Biobricks to the Silver (BioFusion) format
Grunberg, Raik
This Request for Comments (RFC) describes a strategy for converting Biobricks&#13;
from the Freiburg (aka Fusion) format to the Silver lab (aka BioFusion)&#13;
format.
</summary>
<dc:date>2009-03-30T18:33:51Z</dc:date>
</entry>
<entry>
<title>Instructions to BBF RFC Authors</title>
<link href="https://hdl.handle.net/1721.1/44960" rel="alternate"/>
<author>
<name>Tarjan, Daniel</name>
</author>
<author>
<name>Sleight, Sean</name>
</author>
<author>
<name>Shetty, Reshma</name>
</author>
<author>
<name>Ridgway, Doug</name>
</author>
<author>
<name>Rettberg, Randy</name>
</author>
<author>
<name>McArthur, George</name>
</author>
<author>
<name>Mayer, Antonia</name>
</author>
<author>
<name>Knight, Tom</name>
</author>
<author>
<name>French, Chris</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>de Mora, Kim</name>
</author>
<author>
<name>Elfick, Alistair</name>
</author>
<author>
<name>Cowell, Mackenzie</name>
</author>
<author>
<name>Che, Austin</name>
</author>
<author>
<name>Anderson, Chris</name>
</author>
<id>https://hdl.handle.net/1721.1/44960</id>
<updated>2019-04-10T11:14:23Z</updated>
<published>2008-11-10T00:00:00Z</published>
<summary type="text">Instructions to BBF RFC Authors
Tarjan, Daniel; Sleight, Sean; Shetty, Reshma; Ridgway, Doug; Rettberg, Randy; McArthur, George; Mayer, Antonia; Knight, Tom; French, Chris; Endy, Drew; de Mora, Kim; Elfick, Alistair; Cowell, Mackenzie; Che, Austin; Anderson, Chris
This BioBricks Foundation Request for Comments (BBF RFC) provides in-&#13;
formation about the preparation and submission of BBF RFCs to The Bio-&#13;
Bricks Foundation (BBF).
</summary>
<dc:date>2008-11-10T00:00:00Z</dc:date>
</entry>
<entry>
<title>Proposed Conceptual Guidelines for the Design of a BioBrick Graphical Language &amp; an Example</title>
<link href="https://hdl.handle.net/1721.1/44640" rel="alternate"/>
<author>
<name>Fernandez, Eric</name>
</author>
<id>https://hdl.handle.net/1721.1/44640</id>
<updated>2019-04-12T09:52:58Z</updated>
<published>2009-03-12T04:06:23Z</published>
<summary type="text">Proposed Conceptual Guidelines for the Design of a BioBrick Graphical Language &amp; an Example
Fernandez, Eric
As we update the current BioBrick symbols we have an opportunity to look at the&#13;
end users of a BioBrick Graphical language and develop design guidelines so that&#13;
the new symbols best suit their needs. This document explores those needs,&#13;
looks at the design principles necessary to meet them, and puts those principles&#13;
into practice by showing an example of a new set of BioBrick symbols.
</summary>
<dc:date>2009-03-12T04:06:23Z</dc:date>
</entry>
<entry>
<title>The Imperative of Synthetic Biology: A Proposed National Research Initiative</title>
<link href="https://hdl.handle.net/1721.1/43950" rel="alternate"/>
<author>
<name>Lazowska, Ed</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/43950</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2008-12-23T23:49:40Z</published>
<summary type="text">The Imperative of Synthetic Biology: A Proposed National Research Initiative
Lazowska, Ed; Endy, Drew
A 2.5 page report outlining why the United States should launch a strategic national research initiative in synthetic biology
</summary>
<dc:date>2008-12-23T23:49:40Z</dc:date>
</entry>
<entry>
<title>MONOD, a Collaborative Tool for Manipulating Biological Knowledge</title>
<link href="https://hdl.handle.net/1721.1/41867" rel="alternate"/>
<author>
<name>Soergel, David</name>
</author>
<author>
<name>Choi, Kirindi</name>
</author>
<author>
<name>Thomson, Ty</name>
</author>
<author>
<name>Doane, Jay</name>
</author>
<author>
<name>George, Brian</name>
</author>
<author>
<name>Morgan-Linial, Ross</name>
</author>
<author>
<name>Brent, Roger</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/41867</id>
<updated>2025-02-27T21:04:34Z</updated>
<published>2008-06-19T13:10:14Z</published>
<summary type="text">MONOD, a Collaborative Tool for Manipulating Biological Knowledge
Soergel, David; Choi, Kirindi; Thomson, Ty; Doane, Jay; George, Brian; Morgan-Linial, Ross; Brent, Roger; Endy, Drew
We describe an open source software tool called MONOD, for Modeler’s Notebook and Datastore, designed to capture and &#13;
communicate knowledge generated during the process of building models of many-component biological systems. We used &#13;
MONOD to construct a model of the pheromone response signaling pathway of Saccharomyces cerevisiae.  MONOD allowed the &#13;
accumulation, documentation, and exchange of data, valuations, assumptions, and decisions generated during the model building &#13;
process. MONOD thus helped preserve a record of the steps taken on the path between from the experimental data to the computable &#13;
model.  We believe that MONOD and its successors may streamline the processes of building models, communicating with other &#13;
researchers, and managing and manipulating biological knowledge.  "Collaborative annotation"-- fine-grained, structured, &#13;
searchable communication enabled by software tools of this type-- could positively affect the practice of biological research.
Research article written in 2004 describing MONOD, an early biological knowledge management system
</summary>
<dc:date>2008-06-19T13:10:14Z</dc:date>
</entry>
<entry>
<title>Applying engineering principles to the design and construction of transcriptional devices</title>
<link href="https://hdl.handle.net/1721.1/41843" rel="alternate"/>
<author>
<name>Shetty, Reshma P</name>
</author>
<id>https://hdl.handle.net/1721.1/41843</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2008-05-27T20:53:42Z</published>
<summary type="text">Applying engineering principles to the design and construction of transcriptional devices
Shetty, Reshma P
The aim of this thesis is to consider how fundamental engineering principles might best be applied to the design and construction of engineered biological systems. I begin by applying these principles to a key application area of synthetic biology: metabolic engineering. Abstraction is used to compile a desired system function, reprogramming bacterial odor, to devices with human-defined function, then to biological parts, and finally to genetic sequences. Standardization is used to make the process of engineering a multi-component system easier. I then focus on devices that implement digital information processing through transcriptional regulation in Escherichia coli. For simplicity, I limit the discussion to a particular type of device, a trancriptional inverter, although much of the work applies to other devices as well.  First, I discuss basic issues in transcriptional inverter design. Identification of key metrics for evaluating the quality of a static device behavior allows informed device design that optimizes digital performance. Second, I address the issue of ensuring that transcriptional devices work in combination by presenting a framework for developing standards for functional composition. The framework relies on additional measures of device performance, such as error rate and the operational demand the device places on the cellular chassis, in order to proscribe standard device signal thresholds. Third, I develop an experimental, proof-of-principle implementation of a transcriptional inverter based on a synthetic  transcription factor derived from a zinc finger DNA binding domain and a leucine zipper dimerization domain. Zinc fingers and leucine zippers offer a potential scalable solution to the challenge of building libraries of transcription-based logic devices for arbitrary information processing in cells. Finally, I extend the principle of physical composition standards from parts and devices to the vectors that propagate those parts and devices. The new vectors support the assembly of biological systems. Taken together, the work helps to advance the transformation of biological system design from an ad hoc, artisanal craft to a more predictable, engineering discipline.
Ph.D. thesis (user submitted)
</summary>
<dc:date>2008-05-27T20:53:42Z</dc:date>
</entry>
<entry>
<title>pCH1497-ASD1</title>
<link href="https://hdl.handle.net/1721.1/41842" rel="alternate"/>
<author>
<name>Canton, Bartholomew</name>
</author>
<id>https://hdl.handle.net/1721.1/41842</id>
<updated>2019-04-07T07:28:51Z</updated>
<published>2008-05-23T17:07:37Z</published>
<summary type="text">pCH1497-ASD1
Canton, Bartholomew
This plasmid was a kind gift from Christopher Hayes, UCSB.
</summary>
<dc:date>2008-05-23T17:07:37Z</dc:date>
</entry>
<entry>
<title>Software files to support thesis of Ty Thomson</title>
<link href="https://hdl.handle.net/1721.1/41841" rel="alternate"/>
<author>
<name>Thomson, Ty</name>
</author>
<id>https://hdl.handle.net/1721.1/41841</id>
<updated>2019-04-08T07:32:55Z</updated>
<published>2008-05-21T19:36:14Z</published>
<summary type="text">Software files to support thesis of Ty Thomson
Thomson, Ty
</summary>
<dc:date>2008-05-21T19:36:14Z</dc:date>
</entry>
<entry>
<title>Code for simulation of a post-translational latch: ODEs (1)</title>
<link href="https://hdl.handle.net/1721.1/41535" rel="alternate"/>
<author>
<name>Sutton, Samantha</name>
</author>
<id>https://hdl.handle.net/1721.1/41535</id>
<updated>2019-04-06T12:30:55Z</updated>
<published>2008-05-14T17:08:06Z</published>
<summary type="text">Code for simulation of a post-translational latch: ODEs (1)
Sutton, Samantha
This file that contains ODEs describing the post-translational latch. Used with fsolve.
</summary>
<dc:date>2008-05-14T17:08:06Z</dc:date>
</entry>
<entry>
<title>Code for analysis of cytoplasmic and nuclear fluorescence in yeast cells</title>
<link href="https://hdl.handle.net/1721.1/41534" rel="alternate"/>
<author>
<name>Sutton, Samantha</name>
</author>
<id>https://hdl.handle.net/1721.1/41534</id>
<updated>2019-04-07T03:14:02Z</updated>
<published>2008-05-14T17:06:05Z</published>
<summary type="text">Code for analysis of cytoplasmic and nuclear fluorescence in yeast cells
Sutton, Samantha
Matlab code to analyze the nuclear and cytoplasmic fluorescence of yeast cells from micrograph images.
</summary>
<dc:date>2008-05-14T17:06:05Z</dc:date>
</entry>
<entry>
<title>LabView VIs for operating Sortostat</title>
<link href="https://hdl.handle.net/1721.1/41533" rel="alternate"/>
<author>
<name>Kelly, Jason</name>
</author>
<id>https://hdl.handle.net/1721.1/41533</id>
<updated>2019-04-08T07:32:55Z</updated>
<published>2008-05-14T13:39:14Z</published>
<summary type="text">LabView VIs for operating Sortostat
Kelly, Jason
</summary>
<dc:date>2008-05-14T13:39:14Z</dc:date>
</entry>
<entry>
<title>Code for simulation of a post-translational latch: ODEs (2)</title>
<link href="https://hdl.handle.net/1721.1/41532" rel="alternate"/>
<author>
<name>Sutton, Samantha</name>
</author>
<id>https://hdl.handle.net/1721.1/41532</id>
<updated>2019-04-08T07:32:55Z</updated>
<published>2008-05-14T13:33:46Z</published>
<summary type="text">Code for simulation of a post-translational latch: ODEs (2)
Sutton, Samantha
This code contains the ODEs for implementing the post-translational latch, to be fed into fsolve.
</summary>
<dc:date>2008-05-14T13:33:46Z</dc:date>
</entry>
<entry>
<title>Code for simulation of a post-translational latch</title>
<link href="https://hdl.handle.net/1721.1/41531" rel="alternate"/>
<author>
<name>Sutton, Samantha</name>
</author>
<id>https://hdl.handle.net/1721.1/41531</id>
<updated>2019-04-05T23:24:09Z</updated>
<published>2008-05-14T13:33:18Z</published>
<summary type="text">Code for simulation of a post-translational latch
Sutton, Samantha
Code for simulation of a post-translational latch
</summary>
<dc:date>2008-05-14T13:33:18Z</dc:date>
</entry>
<entry>
<title>A Practical Perspective on DNA Synthesis and Biological Security (12/4/2006 Draft)</title>
<link href="https://hdl.handle.net/1721.1/40280" rel="alternate"/>
<author>
<name>Bügl, Hans</name>
</author>
<author>
<name>Danner, John</name>
</author>
<author>
<name>Molinari, Robert</name>
</author>
<author>
<name>Mulligan, John</name>
</author>
<author>
<name>Roth, David</name>
</author>
<author>
<name>Wagner, Ralf</name>
</author>
<author>
<name>Budowle, Bruce</name>
</author>
<author>
<name>Scripp, Robert</name>
</author>
<author>
<name>Smith, Jenifer</name>
</author>
<author>
<name>Steele, Scott</name>
</author>
<author>
<name>Church, George</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/40280</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2006-12-12T20:16:41Z</published>
<summary type="text">A Practical Perspective on DNA Synthesis and Biological Security (12/4/2006 Draft)
Bügl, Hans; Danner, John; Molinari, Robert; Mulligan, John; Roth, David; Wagner, Ralf; Budowle, Bruce; Scripp, Robert; Smith, Jenifer; Steele, Scott; Church, George; Endy, Drew
Few developments have leapfrogged over predecessor technology as quickly and extensively as synthetic &#13;
biology.  Based on cutting-edge DNA synthesis technology, synthetic biology has already fueled an &#13;
expansion of opportunities in biological engineering, with advanced capabilities that surpass those &#13;
provided by traditional recombinant DNA technology.  Improvements in synthesis technology are &#13;
accelerating the pace of innovation in everything from the development of renewable energy to the &#13;
production of bulk and fine chemicals, from information processing to environmental monitoring, and &#13;
from agricultural productivity to breakthroughs in human health and medicine.  Synthetic biology &#13;
promises vast improvements to our well-being and our understanding of the living world. &#13;
Like any powerful technology, DNA synthesis has the potential to be misused.  In the wrong hands, the &#13;
new capabilities enabled by synthetic biology could give rise to both known and unforeseeable threats to &#13;
our biological safety and security.  Current government oversight of the DNA synthesis industry falls &#13;
short of addressing this unfortunate reality. &#13;
Here, we introduce and outline a practical plan for developing an effective governance framework for the &#13;
DNA synthesis industry.  A thoughtfully crafted and effectively implemented framework would protect &#13;
our continued well-being in at least two ways.  First, the framework would promote our biological safety &#13;
and security.  Second, the framework would encourage the further responsible development of synthetic &#13;
biology technologies and their continued, overwhelmingly constructive application. The proposed plan &#13;
represents the collective views of the International Consortium for Polynucleotide Synthesis, the U.S. &#13;
Federal Bureau of Investigation, the Chief Executive Officers or Presidents of several of the principal &#13;
synthetic biology companies, and representatives from academia. &#13;
Our framework calls for the immediate and systematic implementation of a tiered DNA synthesis &#13;
screening process.  In order to establish accountability at the user level, individuals who place orders for &#13;
DNA synthesis would be required to identify themselves, their home organization, and all relevant &#13;
biosafety level information.  Next, individual companies would use software tools to check synthesis &#13;
orders against a set of select agents or sequences to help ensure regulatory compliance and flag synthesis &#13;
orders for further review.  Finally, DNA synthesis and synthetic biology companies would work together, &#13;
and interface with appropriate government agencies, to rapidly and continually improve the underlying &#13;
technologies used to screen orders and identify potentially dangerous sequences, as well as develop a &#13;
clearly defined process to report behavior that falls outside of agreed-upon guidelines.
This is the unabridged draft of the manuscript "DNA synthesis and biological security."  An abridged form of this manuscript was later published as a peer review commentary in Nature Biotechnology (doi:10.1038/nbt0607-627)
</summary>
<dc:date>2006-12-12T20:16:41Z</dc:date>
</entry>
<entry>
<title>Working Papers for Synthetic Genomics: Risks and Benefits for Science and Society</title>
<link href="https://hdl.handle.net/1721.1/39658" rel="alternate"/>
<author>
<name>Garfinkel, Michele</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Epstein, Gerald</name>
</author>
<author>
<name>Friedman, Robert</name>
</author>
<id>https://hdl.handle.net/1721.1/39658</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2007-12-04T17:33:37Z</published>
<summary type="text">Working Papers for Synthetic Genomics: Risks and Benefits for Science and Society
Garfinkel, Michele; Endy, Drew; Epstein, Gerald; Friedman, Robert
The following papers were commissioned for the project Synthetic Genomics: Risks &#13;
and Benefits for Science and Society. These papers formed the basis of many &#13;
discussions at project workshops and at a large invitational meeting. The information &#13;
elicited from these meetings, and from the commissioned papers themselves, formed the &#13;
basis of our report Synthetic Genomics: Options for Governance &#13;
(http://dspace.mit.edu/handle/1721.1/39141). &#13;
 &#13;
The views and opinions expressed in these commissioned papers are those of the authors &#13;
of the papers and not necessarily those of the authors of the report, or of the institutions at &#13;
which the authors work. &#13;
 &#13;
 &#13;
Citation: &#13;
 &#13;
Working Papers for Synthetic Genomics: Risks and Benefits for Science and Society. &#13;
Garfinkel MS, Endy D, Epstein GL, Friedman RM, editors. 2007.
Compilation of Technical Reports in Support of Sloan Foundation study on DNA synthesis and governance options
</summary>
<dc:date>2007-12-04T17:33:37Z</dc:date>
</entry>
<entry>
<title>A Roadmap to the Assembly of Synthetic DNA from Raw Materials</title>
<link href="https://hdl.handle.net/1721.1/39657" rel="alternate"/>
<author>
<name>Sanghvi, Yogesh</name>
</author>
<id>https://hdl.handle.net/1721.1/39657</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-12-04T17:33:04Z</published>
<summary type="text">A Roadmap to the Assembly of Synthetic DNA from Raw Materials
Sanghvi, Yogesh
Until recently, the synthesis of DNA has been a tedious, time consuming, expensive and &#13;
experimentally challenging task. But advances in automated instrumentation and &#13;
improved chemistry have now made it possible to make any moderate-length sequence of &#13;
DNA in any quantity. The ease of automated chemical synthesis of DNA has triggered a &#13;
whole new industry of low-cost DNA suppliers around the globe. The convenience of &#13;
ordering DNA sequence by mail has opened new avenues in research both in academia &#13;
and in the healthcare products developed by pharmaceutical companies.  At the same &#13;
time, these advances have made it theoretically possible to synthesize DNA that could be &#13;
used to do harm.  This article aims to describe the first stages of DNA synthesis, from &#13;
readily available raw materials to medium-sized segments with a desired sequence &#13;
(oligonucleotides), and examines whether there are points at which such activities could &#13;
be, for example, monitored or controlled. Some academic and commercial applications of &#13;
DNA synthesis require the construction of very small quantities of the desired sequence; &#13;
others involve synthesis at the gram scale or larger.  I provide comments on possible &#13;
intervention points for both types of application. Terms shown in bold are defined in the &#13;
glossary.
Technical Report in support of Sloan Foundation study on DNA synthesis and governance options.
</summary>
<dc:date>2007-12-04T17:33:04Z</dc:date>
</entry>
<entry>
<title>Sequence Screening</title>
<link href="https://hdl.handle.net/1721.1/39656" rel="alternate"/>
<author>
<name>Jones, Robert</name>
</author>
<id>https://hdl.handle.net/1721.1/39656</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-12-04T17:32:25Z</published>
<summary type="text">Sequence Screening
Jones, Robert
Currently the vast majority of DNA synthesis is &#13;
performed by service companies or by in-house central facilities in universities and large &#13;
companies. The DNA synthesis industry provides researchers with custom DNA at such &#13;
low cost and with such convenience that almost all synthesis work takes place in a &#13;
relatively small number of facilities. &#13;
 &#13;
A request for DNA synthesis requires that the customer provide the sequence of the &#13;
molecule. This creates the opportunity to monitor or screen input sequences for matches &#13;
to a database of pathogen sequences. Finding a positive match at the time the order was &#13;
received would allow the vendor to alert the relevant authority and to delay shipment of &#13;
that DNA. &#13;
 &#13;
I have written a software package, called BlackWatch, that implements sequence &#13;
screening. This paper will describe the operation of this system, its current shortcomings &#13;
and ways that these might be addressed.
Technical Report in support of the Sloan Foundation study on DNA synthesis and governance options.
</summary>
<dc:date>2007-12-04T17:32:25Z</dc:date>
</entry>
<entry>
<title>From Genetically Modified Organisms To Synthetic Biology: Legislation in the European Union, in Six Member Countries and in Switzerland</title>
<link href="https://hdl.handle.net/1721.1/39655" rel="alternate"/>
<author>
<name>Furger, Franco</name>
</author>
<id>https://hdl.handle.net/1721.1/39655</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2007-12-04T17:31:44Z</published>
<summary type="text">From Genetically Modified Organisms To Synthetic Biology: Legislation in the European Union, in Six Member Countries and in Switzerland
Furger, Franco
This report is based on the assumption that in Europe and in its member countries—with &#13;
the exception perhaps of Switzerland—“synthetic genomics” as a distinct policy domain &#13;
does not yet exist. This conclusion is based on considerable empirical evidence. Since I &#13;
was approached last October (2005) by the project leaders I have systematically been &#13;
monitoring the use of this term in the news media around the (English speaking) world. I &#13;
have done so in two ways: with the help of several Google search robots and by scanning &#13;
various Lexis-Nexis news databases using the term “synthetic genomics” and its &#13;
translation in German, Italian French, Spanish and Dutch.  &#13;
 &#13;
The search has produced very modest results. To date, there has been very few instances &#13;
of news reporting focused on synthetic genomics. One of them was the founding by Dr. &#13;
Craig Venter of Synthetic Genomics. Another one has been the launch of the project this &#13;
review paper has been prepared for. And the third one was the appointment of Dr. Ari &#13;
Patrinos to President of Synthetic Genomics. In addition, there has been sporadic report &#13;
on the discipline itself, but rarely in connection with possible novel risks. With regard to &#13;
Europe, no news stories have been found focusing on synthetic genomics per se or on &#13;
possible new dangers stemming from its development.
Technical report in support of the Sloan Foundation study on DNA synthesis and governance options.
</summary>
<dc:date>2007-12-04T17:31:44Z</dc:date>
</entry>
<entry>
<title>Risk Assessment of Synthetic Genomics: A Biosafety and Biosecurity Perspective</title>
<link href="https://hdl.handle.net/1721.1/39654" rel="alternate"/>
<author>
<name>Fleming, Diane</name>
</author>
<id>https://hdl.handle.net/1721.1/39654</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2007-12-04T17:30:46Z</published>
<summary type="text">Risk Assessment of Synthetic Genomics: A Biosafety and Biosecurity Perspective
Fleming, Diane
The ability to synthesize molecules found in living organisms is not new for scientists in &#13;
the fields of biochemistry and molecular biology. However, the “synthetic biology” made &#13;
possible by the genetic mapping of microorganisms, plants and animals, including the &#13;
human genome, has taken this area of science into new and relatively uncharted territory.  &#13;
The focus here will be on “synthetic genomics” in which genetic information is &#13;
synthesized using chemical components and the genomic DNA sequence of an organism. &#13;
This is how investigators at the State University of New York in Stony Brook, using a &#13;
published genetic sequence, synthesized a DNA version of poliovirus in 2002. Using an &#13;
enzyme, reverse transcriptase, they converted the DNA to RNA and were able to grow &#13;
the virus in a cell-free extract. Their synthesized poliovirus caused paralysis in animals &#13;
(Cello et al., 2002). One of the authors, Eckard Wimmer, warned: “The world had better &#13;
be prepared. This shows you can re-create a virus from written information.”  &#13;
 &#13;
From a biosafety and biosecurity perspective the synthesis of etiologic agents is of &#13;
concern because of the potential to create completely new combinations or chimeric &#13;
genomes with enhanced virulence, extended host range, and resistance to antimicrobials, &#13;
antivirals or vaccines. A major concern is that an agent which has been eradicated as a &#13;
source of infectious disease, such as smallpox, and one which is in the process of being &#13;
eradicated, such as poliovirus, will never be truly eliminated because the information for &#13;
their synthesis is readily available in sequence databases.
Technical report in support of the Sloan Foundation funded study on DNA synthesis and governance.
</summary>
<dc:date>2007-12-04T17:30:46Z</dc:date>
</entry>
<entry>
<title>Impact of Synthetic Genomics on the Threat of Bioterrorism with Viral Agents</title>
<link href="https://hdl.handle.net/1721.1/39653" rel="alternate"/>
<author>
<name>Collett, Marc</name>
</author>
<id>https://hdl.handle.net/1721.1/39653</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2007-12-04T17:28:43Z</published>
<summary type="text">Impact of Synthetic Genomics on the Threat of Bioterrorism with Viral Agents
Collett, Marc
In 2002, a team of researchers at the State University of New York led by Eckard &#13;
Wimmer assembled a DNA template for the RNA poliovirus using an internet-available &#13;
nucleotide sequence and mail order synthetic oligonucleotides.  Using a routine &#13;
laboratory procedure, they then converted the DNA into RNA and produced an &#13;
infectious, neurovirulent poliovirus capable of paralyzing and killing mice.1   &#13;
 &#13;
This work demonstrated clearly for the first time the feasibility of chemically &#13;
synthesizing a pathogen knowing only its nucleotide sequence.  Some called the work &#13;
“irresponsible,” and there was widespread speculation in the press that bioterrorists might &#13;
use the technology to create more virulent viruses, such as smallpox, from published gene &#13;
sequences or create novel, more lethal viruses.  Wimmer countered that “an evildoer &#13;
would not use that very tedious method to synthesize a virus. That terrorist would rather &#13;
use already existing viruses in nature.” 2   &#13;
 &#13;
Indeed, all viruses, from the common cold to the deadliest, originate in nature, being &#13;
identified and isolated from infected humans or animals or the virus’s animal or insect &#13;
vector. However, the rapidly advancing technology of whole genome assembly &#13;
(“synthetic genomics”) is making the chemical synthesis of viral genomes a much less &#13;
tedious endeavor.3 &#13;
 &#13;
This paper will explore the potential impact of synthetic genomics technology on the &#13;
risks of a bioterrorist attack using viral pathogens.
Technical report in support of Sloan Foundation study on DNA synthesis and governance.
</summary>
<dc:date>2007-12-04T17:28:43Z</dc:date>
</entry>
<entry>
<title>Synthetic Viral Genomics: Risks and Benefits for Science and Society</title>
<link href="https://hdl.handle.net/1721.1/39652" rel="alternate"/>
<author>
<name>Baric, Ralph</name>
</author>
<id>https://hdl.handle.net/1721.1/39652</id>
<updated>2025-02-27T21:05:21Z</updated>
<published>2007-12-04T17:28:00Z</published>
<summary type="text">Synthetic Viral Genomics: Risks and Benefits for Science and Society
Baric, Ralph
Viral disease outbreaks have long inspired fear in human populations. Highly pathogenic &#13;
infectious disease has shaped world history, primarily by impacting the outcome of wars &#13;
and other global conflicts and precipitating human movement. Historic accounts have &#13;
documented the catastrophic consequences and human suffering associated with &#13;
widespread viral outbreaks like smallpox virus, yellow fever virus, measles virus, human &#13;
immunodeficiency virus (HIV), the severe acute respiratory syndrome coronavirus &#13;
(SARS-CoV), the 1918 influenza virus and others (51). News accounts and film have &#13;
reinforced the serious threat posed by the emergence of new viral diseases as well as the &#13;
catastrophic consequences of intentional release of highly pathogenic viruses in human &#13;
populations. As illustrated by the SARS epidemic and the continuing evolution of the &#13;
H5N1 avian influenza, global and national infectious disease outbreaks can overwhelm &#13;
disaster medical response networks and medical facilities, disrupt global economies, and &#13;
paralyze health and medical services by targeting health care workers and medical staff &#13;
(21).  This review focuses on viruses of humans, animals and plants that are viewed as &#13;
potential weapons of mass disruption to human populations, critical plant and animal &#13;
food sources, and national economies; and will consider whether and how the availability &#13;
of synthetic genomics technologies will change this landscape.
Technical Report in support of Sloan Foundation sponsored study on DNA synthesis governance options
</summary>
<dc:date>2007-12-04T17:28:00Z</dc:date>
</entry>
<entry>
<title>Synthetic Genomics: Options for Governance</title>
<link href="https://hdl.handle.net/1721.1/39141" rel="alternate"/>
<author>
<name>Garfinkel, Michele</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Epstein, Gerald</name>
</author>
<author>
<name>Friedman, Robert</name>
</author>
<id>https://hdl.handle.net/1721.1/39141</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-10-17T17:50:40Z</published>
<summary type="text">Synthetic Genomics: Options for Governance
Garfinkel, Michele; Endy, Drew; Epstein, Gerald; Friedman, Robert
Gene and genome synthesis, that is, constructing long stretches of DNA from constituent chemicals, provides scientists with new and unparalleled capabilities both for understanding biology and for using it for beneficial purposes. But along with new capabilities come new risks.
Discussion of policy options for regulation of DNA synthesis technology.
</summary>
<dc:date>2007-10-17T17:50:40Z</dc:date>
</entry>
<entry>
<title>Registry of BioBricks Models using CellML</title>
<link href="https://hdl.handle.net/1721.1/39120" rel="alternate"/>
<author>
<name>Vincent Rouilly, Barry Canton</name>
</author>
<author>
<name>Poul Nielsen, Richard Kitney</name>
</author>
<id>https://hdl.handle.net/1721.1/39120</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-10-04T21:47:21Z</published>
<summary type="text">Registry of BioBricks Models using CellML
Vincent Rouilly, Barry Canton; Poul Nielsen, Richard Kitney
One of the main goals in Synthetic Biology is to assess the feasibility of building novel biological systems from interchangeable and standardized parts. In order to collect and share parts, a Registry of standardized DNA BioBricks[1] has been established at MIT.  BioBricks can be assembled to form devices and systems to operate in living cells. Design of reliable devices and systems would benefit from accurate models of system function. To predict the function of systems built from many parts, we need to have accurate models for the parts and mechanisms to easily compose those part models into a system model. Therefore, in parallel to increasing the number of parts available and &#13;
characterising them experimentally, a logical extension to the Registry would be to build a Registry of BioBrick models to complement the physical parts.
A poster presented at BioSysBio 2007 and at SB3.0
</summary>
<dc:date>2007-10-04T21:47:21Z</dc:date>
</entry>
<entry>
<title>2003 Synthetic Biology study</title>
<link href="https://hdl.handle.net/1721.1/38455" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/38455</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-08-14T22:52:47Z</published>
<summary type="text">2003 Synthetic Biology study
Endy, Drew
Biology is a technology for processing information, materials, and energy.  As a technology platform, biological systems provide access to artifacts and processes across a range of scales (e.g., the ribosome is a programmable nanoassembler, a bamboo shoot can grow 12” per day).  Biology also forms the basis for human welfare (e.g., modest amounts of memory and logic, implemented as genetically encoded systems,would directly impact biological &#13;
research and medicine).  However, our ability to deploy biology as a technology and to interact intentionally with the living world is now limited; the charge to our study was to begin to specify enabling technologies &#13;
that, if developed, would provide a general foundation for the engineering of biology and make routine the creation of synthetic biological systems that behave as predicted.
This is the final report of the 2002-2003 synthetic biology study, which brought together ~50 researchers to discuss an improved framework for engineering biology.  The report itself takes the form of an annotated presentation and was written for a general technical audience.  This study built upon a smaller, earlier study led by Tom Knight (unpublished at this time).
</summary>
<dc:date>2007-08-14T22:52:47Z</dc:date>
</entry>
<entry>
<title>Engineering transcription-based digital logic devices</title>
<link href="https://hdl.handle.net/1721.1/37820" rel="alternate"/>
<author>
<name>Shetty, Reshma P.</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<author>
<name>Knight, Thomas F. Jr</name>
</author>
<id>https://hdl.handle.net/1721.1/37820</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-07-17T03:09:54Z</published>
<summary type="text">Engineering transcription-based digital logic devices
Shetty, Reshma P.; Endy, Drew; Knight, Thomas F. Jr
Implementing in vivo information processing is a key challenge in synthetic biology.  We describe the construction and characterization of digital transcription-based devices from zinc fingers and leucine zippers.  We also present a framework around device design and performance.
Poster presented at Synthetic Biology 3.0: The third international conference in synthetic biology.
</summary>
<dc:date>2007-07-17T03:09:54Z</dc:date>
</entry>
<entry>
<title>Analysis of Targeted and Combinatorial Approaches to Phage T7 Genome Generation</title>
<link href="https://hdl.handle.net/1721.1/35880" rel="alternate"/>
<author>
<name>Mallet, Alex</name>
</author>
<id>https://hdl.handle.net/1721.1/35880</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-02-06T16:41:27Z</published>
<summary type="text">Analysis of Targeted and Combinatorial Approaches to Phage T7 Genome Generation
Mallet, Alex
I performed computational analyses of various approaches to generating re- &#13;
engineered versions of the genome of bacteriophage T7. I analyzed a proposed design for a &#13;
re-engineered genome by examining conservation of T7 genes across related phages, and &#13;
looking for RNA secondary structure arising from the re-engineered genome that might &#13;
contribute to unwanted regulation. In addition, I proposed two methods of generating &#13;
libraries of T7 genomes, and implemented simulations showing that the proposed methods &#13;
are theoretically feasible. I conclude with thoughts on how to further validate my proposed &#13;
approaches to genome generation, and suggest a specific high-throughput method of &#13;
characterizing rebuilt genomes.
</summary>
<dc:date>2007-02-06T16:41:27Z</dc:date>
</entry>
<entry>
<title>Simulation, Models, and Refactoring of Bacteriophage T7</title>
<link href="https://hdl.handle.net/1721.1/35864" rel="alternate"/>
<author>
<name>Kosuri, Sriram</name>
</author>
<id>https://hdl.handle.net/1721.1/35864</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2007-02-02T13:46:50Z</published>
<summary type="text">Simulation, Models, and Refactoring of Bacteriophage T7
Kosuri, Sriram
Our understanding of why biological systems are designed in a particular way&#13;
would benefit from biophysically-realistic models that can make accurate predictions on the time-evolution of molecular events given arbitrary arrangements of genetic components. This thesis is focused on constructing such models for gene expression during bacteriophage T7 infection. T7 gene expression is a particularly well suited model system because knowledge of how the phage functions is thought to be relatively complete. My work focuses on two questions in particular. First, can we address deficiencies in past simulations and measurements of bacteriophage T7 to improve models of gene expression? Second, can we design and build refactored surrogates of T7 that are easier to understand and model?  &#13;
&#13;
To address deficiencies in past simulations and measurements, I developed a new single-molecule, base-pair-resolved gene expression simulator named Tabasco that can faithfully represent mechanisms thought to govern phage gene expression. I used Tabasco to construct a model of T7 gene expression that encodes our mechanistic understanding. The model displayed significant discrepancies from new system-wide measurements of absolute T7 mRNA levels during infection. I fit transcript-specific degradation rates to match the measured RNA levels and as a result corrected discrepancies in protein synthesis rates that confounded previous models. I also developed and used a fitting procedure to the data that let us evaluate assumptions related to promoter strengths, mRNA degradation, and polymerase interactions.  &#13;
&#13;
To construct surrogates of T7 that are easier to understand and model, I began the process of refactoring the T7 genome to construct an organism that is a more direct representation of the models that we build. In other words, instead of making our models evermore detailed to explain wild-type T7, we started to construct new phage that are more direct representations of our models. The goal of our original design, T7.1, was to physically define, separate, and enable unique manipulation of primary genetic elements.  To test our initial design, we replaced the left 11,515 bp of the wild-type genome with 12,179 bp of engineered DNA. The resulting chimeric genome encodes a viable bacteriophage that appears to maintain key features of the original while being simpler to model and easier to manipulate. I also present a second generation design, T7.2, that extends the original goals of T7.1 by constructing a more direct physical representation of the T7 model.
</summary>
<dc:date>2007-02-02T13:46:50Z</dc:date>
</entry>
<entry>
<title>Code accompanying "Analysis of Targeted and Combinatorial Approaches to Phage T7 Genome Generation" Master's Thesis</title>
<link href="https://hdl.handle.net/1721.1/34915" rel="alternate"/>
<author>
<name>Mallet, Alex</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/34915</id>
<updated>2019-04-08T08:07:54Z</updated>
<published>2006-11-26T18:44:48Z</published>
<summary type="text">Code accompanying "Analysis of Targeted and Combinatorial Approaches to Phage T7 Genome Generation" Master's Thesis
Mallet, Alex; Endy, Drew
Code accompanying "Analysis of Targeted and Combinatorial Approaches to Phage T7 Genome Generation" Master's Thesis.
This submission is a zip file containing the code used to generate the results described in Alex Mallet's 2007 Master's Thesis in Computational and Systems Biology.
</summary>
<dc:date>2006-11-26T18:44:48Z</dc:date>
</entry>
<entry>
<title>In the valley of the shadow of death</title>
<link href="https://hdl.handle.net/1721.1/34914" rel="alternate"/>
<author>
<name>Brent, Roger</name>
</author>
<id>https://hdl.handle.net/1721.1/34914</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2006-11-22T00:00:00Z</published>
<summary type="text">In the valley of the shadow of death
Brent, Roger
During the 20th century, advances in biological understanding sparked a global &#13;
revolution in biological capability, or RBC.  Since that time, the revolution has proceeded &#13;
in a Moore's-law-like fashion for many decades.  One negative consequence of the RBC &#13;
is that the US now faces a large and growing threat of catastrophic biological attack.  To &#13;
deal with the threat, this article advocates a two-part strategy. First, during the current &#13;
period of high and growing risk, Period 1, "the Valley of the Shadow of Death", the US &#13;
should bring into being a patchwork of agile technical capabilities to detect and respond &#13;
to attacks, and social and normative policies to diminish their risk of occurrence.  Second &#13;
and simultaneously, the US should initiate research whose fruits will eventually deter &#13;
biological attacks by rendering them "impotent and obsolete". Creation of effective, &#13;
responsive, and agile Period 1 capabilities will buy time, by lowering the probability of &#13;
attacks and blunting their impact, until strong technical defenses enabled by longer-term &#13;
research can become operational in Period 2.  Executing the two components of this &#13;
strategy will be far more costly and complex than is generally contemplated, albeit &#13;
probably less expensive and difficult than execution of the containment strategy during &#13;
the Cold War.  However, the increased security, human health and felicity, and economic &#13;
growth that this activity will engender will repay the effort and cost many times over.  &#13;
Entry into Period 2, defense so strong as to deter attack by making it unlikely to have any &#13;
effect, coincides with the effective elimination of most naturally occurring infectious &#13;
diseases as a factor in human affairs.  But at the moment, the best names for Period 2 &#13;
seem to be "Partial Victory" or "Basin and Range", in that later trends may shift once &#13;
again to favor attack.
Roger Brent provides a commentary on current and future biological security challenges and possible strategies / approaches.
</summary>
<dc:date>2006-11-22T00:00:00Z</dc:date>
</entry>
<entry>
<title>Power and responsibility</title>
<link href="https://hdl.handle.net/1721.1/34913" rel="alternate"/>
<author>
<name>Brent, Roger</name>
</author>
<id>https://hdl.handle.net/1721.1/34913</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2006-11-21T23:56:44Z</published>
<summary type="text">Power and responsibility
Brent, Roger
Peter Parker and Uncle Ben are on my mind.  The reason is that is that a month ago I &#13;
was jumped by Craig Venter.  There were TV cameras around.  The live audience was an &#13;
interesting, edgy mix, on the interface between "technology", meaning computer &#13;
technology, and culture/ media/ journalism; I had just given a closely prepared talk on the &#13;
history, promises, and perils of biology, 20 minutes from solar system formation to origin &#13;
of life to photosynthesis to agriculture to Asilomar to now; and I had paid particular &#13;
attention to the existing threat from remade and lightly engineered viruses, and the &#13;
various technology-empowered approaches that could contribute to a defense against &#13;
unpredictable viral and bacterial pathogens. The whole set of ways the defense strategy &#13;
needs to shift.
A commentary from Roger Brent on synthetic biology and its relation to issues of personal responsibility and biological security.
</summary>
<dc:date>2006-11-21T23:56:44Z</dc:date>
</entry>
<entry>
<title>SYNTHETIC BIOLOGY: CAUGHT BETWEEN PROPERTY RIGHTS, THE PUBLIC DOMAIN, AND THE COMMONS</title>
<link href="https://hdl.handle.net/1721.1/34274" rel="alternate"/>
<author>
<name>Rai, Arti</name>
</author>
<author>
<name>Boyle, James</name>
</author>
<id>https://hdl.handle.net/1721.1/34274</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2006-11-05T00:00:00Z</published>
<summary type="text">SYNTHETIC BIOLOGY: CAUGHT BETWEEN PROPERTY RIGHTS, THE PUBLIC DOMAIN, AND THE COMMONS
Rai, Arti; Boyle, James
Preprint of Rai and Boyle article to be published in PLoS Biology.  Pre-published here with permission of author's and PLoS Editor (below).  &#13;
&#13;
From:   RAI@law.duke.edu&#13;
Subject: Re: quick question&#13;
Date: November 3, 2006 1:20:42 PM EST&#13;
To:   endy@MIT.EDU&#13;
&#13;
Here you go. (You can post it as a draft, forthcoming in PLoS Biology.)  EIC is editor in chief. Thanks so much for doing this!
</summary>
<dc:date>2006-11-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>May 2006 correspondance between James Randerson and Drew Endy</title>
<link href="https://hdl.handle.net/1721.1/33001" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/33001</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2006-06-15T14:39:41Z</published>
<summary type="text">May 2006 correspondance between James Randerson and Drew Endy
Endy, Drew
I am a science journalist with the Guardian newspaper in London. We are a national daily paper. I am hoping to put together an investigative piece on how easy (or not) it would be for a would-be terrorist to put together the genome of a nasty organism like anthrax from scratch. For the purposes of the piece I am planning to approach a DNA synthesis company and ask them to make a fragment of a nasty toxin gene. Some companies have safeguards in place to prevent this kind of thing but others do not. (continued)
</summary>
<dc:date>2006-06-15T14:39:41Z</dc:date>
</entry>
<entry>
<title>Public Draft of the Declaration of the Second International Meeting on Synthetic Biology</title>
<link href="https://hdl.handle.net/1721.1/32982" rel="alternate"/>
<author>
<name>Conferees, SB2.0</name>
</author>
<id>https://hdl.handle.net/1721.1/32982</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2006-05-30T19:27:35Z</published>
<summary type="text">Public Draft of the Declaration of the Second International Meeting on Synthetic Biology
Conferees, SB2.0
Draft public declaration from the Second International Meeting on Synthetic Biology (May 20-22, 2006, Berkeley, CA)
</summary>
<dc:date>2006-05-30T19:27:35Z</dc:date>
</entry>
<entry>
<title>GeneJax: A Prototype CAD tool in support of Genome Refactoring</title>
<link href="https://hdl.handle.net/1721.1/32981" rel="alternate"/>
<author>
<name>Anand, Ishan</name>
</author>
<author>
<name>Kosuri, Sriram</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/32981</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2006-05-26T19:40:06Z</published>
<summary type="text">GeneJax: A Prototype CAD tool in support of Genome Refactoring
Anand, Ishan; Kosuri, Sriram; Endy, Drew
Refactoring is a technique used by computer scientists for improving program design. The Endy Laboratory has adapted this process to make the genomes of biological organisms more amenable to human understanding and design goals. To assist in this endeavor, we implemented GeneJax, a prototype JavaScript web application for the dissection and visualization stages of the genome refactoring process. This paper reviews key genome refactoring concepts and then discusses the features, development history, user-interface, and underlying implementation issues faced during the making of GeneJax. In addition, we provide recommendations for future GeneJax development. This paper may be of interest to engineers of CAD tools for synthetic biology.
</summary>
<dc:date>2006-05-26T19:40:06Z</dc:date>
</entry>
<entry>
<title>A New Biobrick Assembly Strategy Designed for Facile Protein Engineering</title>
<link href="https://hdl.handle.net/1721.1/32535" rel="alternate"/>
<author>
<name>Phillips, Ira</name>
</author>
<author>
<name>Silver, Pamela</name>
</author>
<id>https://hdl.handle.net/1721.1/32535</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2006-04-20T23:42:53Z</published>
<summary type="text">A New Biobrick Assembly Strategy Designed for Facile Protein Engineering
Phillips, Ira; Silver, Pamela
The existing biobrick assembly technique[1] provides a straightforward&#13;
way to combine standardized biological components, termed biobricks.&#13;
This system, however, is limited in that each protein-encoding biobrick&#13;
must contain a complete translated region. Signal sequences or other protein&#13;
domains often convey a specific function to the protein to which they&#13;
are attached; hence, each domain should be considered an independent&#13;
biological part. With the current assembly technique, assembling such&#13;
parts is not possible. This paper presents a revised assembly strategy&#13;
that is compatible with the current biobrick definition and permits the&#13;
construction of fusion proteins.
</summary>
<dc:date>2006-04-20T23:42:53Z</dc:date>
</entry>
<entry>
<title>Definitions and Measures of Performance for Standard Biological Parts</title>
<link href="https://hdl.handle.net/1721.1/31335" rel="alternate"/>
<author>
<name>Conboy, Caitlin</name>
</author>
<author>
<name>Braff, Jen</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/31335</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2006-03-16T02:20:49Z</published>
<summary type="text">Definitions and Measures of Performance for Standard Biological Parts
Conboy, Caitlin; Braff, Jen; Endy, Drew
We are working to enable the engineering of integrated biological systems.  Specifically, we would like to be able to build systems using standard parts that, when combined, have reliable and predictable behavior.  Here, we define standard characteristics for describing the absolute physical performance of genetic parts that control gene expression.  The first characteristic, PoPS, defines the level of transcription as the number of RNA polymerase molecules that pass a point on DNA each second, on a per DNA copy basis (PoPS = Polymerase Per Second; PoPSdc = PoPS per DNA copy).  The second characteristic, RiPS, defines the level of translation as the number of ribosome molecules that pass a point on mRNA each second, on a per mRNA copy basis (RiPS = Ribosomes Per Second; RiPSmc = RiPS per mRNA copy).  In theory, it should be possible to routinely combine devices that send and receive PoPS and RiPS signals to produce gene expression-based systems whose quantiative behavior is easy to predict.  To begin to evaluate the utility of the PoPS and RIPS framework we are characterizing the performance of a simple gene expression device in E. coli growing at steady state under standard operating conditions; we are using a simple ordinary differential equation model to estimate the steady state PoPS and RiPS levels.
Poster presented at the 2005 ICSB meeting, held at Harvard Medical School in Boston, MA.
</summary>
<dc:date>2006-03-16T02:20:49Z</dc:date>
</entry>
<entry>
<title>Strategy for Biological Risk &amp; Security</title>
<link href="https://hdl.handle.net/1721.1/30595" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/30595</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2003-10-01T00:00:00Z</published>
<summary type="text">Strategy for Biological Risk &amp; Security
Endy, Drew
Why do biological risks exist?  Can we develop and implement a strategy for thoughtfully approaching future biological risks?  This short, working report provides an abstract introduction to the problem of biological risk and outlines how technical and societal approaches should be combined in order to best address the challenge.
</summary>
<dc:date>2003-10-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Engineered Post-Translational Logic (PTL)</title>
<link href="https://hdl.handle.net/1721.1/29804" rel="alternate"/>
<author>
<name>Sutton, Samantha</name>
</author>
<author>
<name>Neves, Sara</name>
</author>
<author>
<name>Leung, Lauren</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/29804</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2005-12-07T23:32:00Z</published>
<summary type="text">Engineered Post-Translational Logic (PTL)
Sutton, Samantha; Neves, Sara; Leung, Lauren; Endy, Drew
Current synthetic biological circuits make use of protein-DNA and RNA-RNA interactions to control gene expression in bacteria. Systems that rely on the regulation of gene expression are relatively slow and unsuitable for many applications. Here, we describe our work to engineer synthetic biological systems in yeast using post-translational modifications of proteins to define system state and control cell function; such systems should have faster performance time and enable a wider range of applications. We have specifically chosen to focus on building phosphorylation-driven protein circuits. We modeled a specific instance of a post-translational circuit using methods such as Lyapunov exponents, and showed that the circuit should behave as desired within a large parameter space. We developed a set of peptide tags that can be used to drive the phosphorylation of a chosen substrate by a desired mitogen-activated protein kinase (MAPK). Each phosphorylation event alters a substrate output activity, such as translocation, degradation, or other binding event. These tags were developed using the Phospholocator – a construct whose phosphorylation-mediated translocation is controlled by MAPK activity. Specifically, MAPK phosphorylation of the Phospholocator nuclear localization sequence (NLS) controls recognition of the NLS by cellular import machinery. The Phospholocator serves three purposes: to determine the docking sites of MAPKs of interest, to measure the in vivo activity of such MAP Kinases, and to serve as a first set of post-translational logic parts. Currently, we have built a version of the Phospholocator that is targeted by Cdc28; our next step is to build Fus3-, p38-, and Hog1-activated instances.
This poster was presented at the 2005 International Conference on Systems Biology, October 21, 2005.
</summary>
<dc:date>2005-12-07T23:32:00Z</dc:date>
</entry>
<entry>
<title>Rapid Characterization of Cellular Pathways Using Time-Varying Signals</title>
<link href="https://hdl.handle.net/1721.1/29803" rel="alternate"/>
<author>
<name>Thomson, Ty M</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/29803</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2005-10-21T00:00:00Z</published>
<summary type="text">Rapid Characterization of Cellular Pathways Using Time-Varying Signals
Thomson, Ty M; Endy, Drew
The use of traditional tools for the discovery and characterization of biological systems has resulted in a wealth of biological knowledge.  Unfortunately, only a small portion of the biological world is well-understood to date, and the study of the rest remains a daunting task.  This work involves using time-varying stimuli in order to more rapidly interrogate and characterize signaling pathways.  The time-dependent stimulation of a signaling pathway can be used in conjunction with a model of the pathway to efficiently evaluate and test hypotheses.  We are developing this technology using the yeast pheromone signal transduction pathway as a model system. The time-varying stimuli will be applied to the yeast cells via a novel microfluidic device, and the pathway output will be measured via various fluorescent reporters.  The output of the pathway can then be compared to the output from a computational model of the pathway in order to test hypotheses and constrain our knowledge of the pathway.  Initial work shows that a computational model can be used to identify stimuli time-courses that increase the parameter sensitivity, meaning that corresponding experiments could potentially be much more informative.
Poster presented at the 2005 ICSB meeting, held at Harvard Medical School in Boston, MA.
</summary>
<dc:date>2005-10-21T00:00:00Z</dc:date>
</entry>
<entry>
<title>Engineering the Interface Between Cellular Chassis and Integrated Biological Systems</title>
<link href="https://hdl.handle.net/1721.1/29802" rel="alternate"/>
<author>
<name>Canton, Bartholomew</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/29802</id>
<updated>2025-02-27T21:05:21Z</updated>
<published>2005-10-21T00:00:00Z</published>
<summary type="text">Engineering the Interface Between Cellular Chassis and Integrated Biological Systems
Canton, Bartholomew; Endy, Drew
The engineering of biological systems with predictable behavior is a challenging problem.  One reason for this difficulty is that engineered biological systems are embedded within complex and variable host cells.  To help enable the future engineering of biological systems, we are studying and optimizing the interface between an engineered biological system and its host cell or ``chassis''.  Other engineering disciplines use modularity to make interacting systems interchangeable and to insulate one system from another.  Engineered biological systems are more likely to work as predicted if system function is decoupled from the state of the host cell.  Also, specifying and standardizing the interfaces between a system and the chassis will allow systems to be engineered independent of chassis and allow systems to be interchanged between different chassis. To this end, we have assembled orthogonal transcription and translation systems employing dedicated machinery, independent from the equivalent host cell machinery. In parallel, we are developing test systems and metrics to measure the interactions between an engineered system and its chassis.  Lastly, we are exploring methods to``port'' a simple engineered system from a prokaryotic to a eukaryotic organism so that the system can function in both organisms.
Poster presented at the 2005 ICSB meeting, held at Harvard Medical School in Boston, MA.
</summary>
<dc:date>2005-10-21T00:00:00Z</dc:date>
</entry>
<entry>
<title>Engineering transcription-based digital logic devices</title>
<link href="https://hdl.handle.net/1721.1/29800" rel="alternate"/>
<author>
<name>Shetty, Reshma P.</name>
</author>
<author>
<name>Knight, Thomas F. Jr</name>
</author>
<id>https://hdl.handle.net/1721.1/29800</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2005-10-20T00:00:00Z</published>
<summary type="text">Engineering transcription-based digital logic devices
Shetty, Reshma P.; Knight, Thomas F. Jr
The goal of Synthetic Biology is to engineer systems from biological parts.  One class of systems are those whose purpose is to process information.  My work seeks to build transcription-based devices for use in combinational digital logic.  Preliminary characterization experiments show that existing devices fall short of desired device behavior.  I propose to develop a novel implementation of transcription-based logic by designing synthetic transcription factors from well-characterized DNA binding and dimerization domains.  Initial modeling work serves to inform design of these devices.
Poster presented at the 2005 ICSB meeting, held at Harvard Medical School in Boston, MA.
</summary>
<dc:date>2005-10-20T00:00:00Z</dc:date>
</entry>
<entry>
<title>Design and Evolution of Engineered Biological Systems</title>
<link href="https://hdl.handle.net/1721.1/29799" rel="alternate"/>
<author>
<name>Kelly, Jason</name>
</author>
<author>
<name>Michener, Josh</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/29799</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2005-10-20T00:00:00Z</published>
<summary type="text">Design and Evolution of Engineered Biological Systems
Kelly, Jason; Michener, Josh; Endy, Drew
To date, engineered biological systems have been constructed via a variety of&#13;
ad hoc approaches. The resulting systems should be thought of as pieces of&#13;
art. We are interested in exploring how existing forward engineering&#13;
approaches might be combined with directed evolution to make routine the&#13;
construction of engineered biological systems. We have specified a&#13;
procedure for construction of biological systems via screening of&#13;
subcomponent libraries and rational re-assembly. We have begun&#13;
development of tools to enable this approach, including a FACS-based&#13;
screening system to rapidly measure the input/output function of a genetic&#13;
circuit. Additionally, we have designed a microfluidic system that enables&#13;
more sophisticated screening and selection functions. Specifically, a&#13;
microfluidic chemostat integrated with a cell sorter (i.e., a sortostat). This&#13;
microscope-based system will enable us to evaluate whether or not more&#13;
complicated screens and selections will be of practical use in service of&#13;
evolving engineered biological systems.
Poster presented at the 2005 ICSB meeting, held at Harvard Medical School in Boston, MA.
</summary>
<dc:date>2005-10-20T00:00:00Z</dc:date>
</entry>
<entry>
<title>A Standard Parts List for Biological Circuitry</title>
<link href="https://hdl.handle.net/1721.1/29794" rel="alternate"/>
<author>
<name>Arkin, Adam P</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/29794</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>1999-10-07T00:00:00Z</published>
<summary type="text">A Standard Parts List for Biological Circuitry
Arkin, Adam P; Endy, Drew
One of the hallmarks of biochemical circuits found in nature is analog, asymmetric, asynchronous design. That&#13;
is, there is little standardization of parts, e.g. all the promoters have different strengths and kinetics,&#13;
transcription factors are designed to have different effects at different loci, and each enzymatic reaction has its own&#13;
idiosyncratic mechanism and rates. In addition, all of the heterogeneous circuit elements are executing their&#13;
functions concurrently and asynchronously. Biological circuits are seemingly designed to deal with the&#13;
fluctuating delays, different time-scales and energy requirements associated with each component process of the&#13;
overall network. These factors also make design of novel biochemical circuitry from existent parts difficult to&#13;
achieve. Without standardization, the qualitative design methods used in other engineering fields are simply&#13;
inapplicable. The de facto design methodology for biological circuitry is natural selection. Rational design of&#13;
biological systems by humans has remained restricted to rather small or hit-or-miss efforts and has often relied&#13;
on the ability to "select" for biochemical parts that fulfill some criteria. In practice however biological-designers&#13;
are rare, and solutions are usually realized through an expensive stepwise trial and error approach or through&#13;
mutation and selection. Furthermore, these otherwise practical approaches are limited in terms of the problems&#13;
they can solve. We believe that implementation of designed biological circuitry is limited by issues of practice.
</summary>
<dc:date>1999-10-07T00:00:00Z</dc:date>
</entry>
<entry>
<title>Cellular Gate Technology</title>
<link href="https://hdl.handle.net/1721.1/29793" rel="alternate"/>
<author>
<name>Knight, Thomas F.</name>
</author>
<author>
<name>Sussman, Gerald Jay</name>
</author>
<id>https://hdl.handle.net/1721.1/29793</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>1998-01-05T00:00:00Z</published>
<summary type="text">Cellular Gate Technology
Knight, Thomas F.; Sussman, Gerald Jay
We propose a biochemically plausible mechanism for constructing digital logic signals and gates of significant complexity within living cells. These mechanisms rely largely on co-opting existing biochemical machinery and binding proteins found naturally within the cell, replacing difficult protein engineering problems with more straightforward engineering of novel combinations of gene control sequences and gene coding regions. The resulting logic technology, although slow, allows us to engineer the chemical behavior of cells for use as sensors and effectors. One promising use of such technology is the control of fabrication processes at the molecular scale.
</summary>
<dc:date>1998-01-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>iGEM 2005 Invitation Supplement</title>
<link href="https://hdl.handle.net/1721.1/29183" rel="alternate"/>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/29183</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2005-09-29T17:09:25Z</published>
<summary type="text">iGEM 2005 Invitation Supplement
Endy, Drew
This document provides background material in support of the 2005 intercollegiate Genetically Engineered Machine Competition (aka iGEM).  Herein, you can read quick summaries of earlier competitions and courses, obtain a general view of the work from both a technical and educational perspective, and read about our current understanding of how to engineering biology (e.g., PoPS, abstraction, and so on).
</summary>
<dc:date>2005-09-29T17:09:25Z</dc:date>
</entry>
<entry>
<title>Refactoring Bacteriophage T7 (2004 version)</title>
<link href="https://hdl.handle.net/1721.1/27501" rel="alternate"/>
<author>
<name>Chan, Leon</name>
</author>
<author>
<name>Kosuri, Sriram</name>
</author>
<author>
<name>Endy, Drew</name>
</author>
<id>https://hdl.handle.net/1721.1/27501</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2004-10-01T00:00:00Z</published>
<summary type="text">Refactoring Bacteriophage T7 (2004 version)
Chan, Leon; Kosuri, Sriram; Endy, Drew
Natural biological systems are selected by evolution to continue to exist. Evolution might&#13;
give rise to complicated systems that are difficult to discover, measure, model, and direct.&#13;
Here, we redesign the genome of a natural biological system, bacteriophage T7, in order&#13;
to specify an engineered alternative that is easier to study, understand, and extend. We&#13;
replaced the left 11,515 base pairs of the wild-type genome with 12,179 base pairs of&#13;
redesigned DNA. The resulting chimeric genome encodes a viable bacteriophage that&#13;
maintains key features of the original while being simpler to model and easier to&#13;
manipulate.
This document is an prior version of the manuscript 'Refactoring Bacteriophage T7' that is now published in Nature/EMBO Molecular Systems Biology (DOI: 10.1038/msb4100025).  This DSpace manuscript is more concise but provides less context than the MSB manuscript.
</summary>
<dc:date>2004-10-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Cellular computation and communications using engineered genetic regulatory networks</title>
<link href="https://hdl.handle.net/1721.1/8228" rel="alternate"/>
<author>
<name>Weiss, Ron, 1970-</name>
</author>
<id>https://hdl.handle.net/1721.1/8228</id>
<updated>2022-01-13T07:54:29Z</updated>
<published>2001-01-01T00:00:00Z</published>
<summary type="text">Cellular computation and communications using engineered genetic regulatory networks
Weiss, Ron, 1970-
In this thesis, I present an engineering discipline for obtaining complex, predictable, and reliable cell behaviors by embedding biochemical logic circuits and programmed intercellular communications into cells. To accomplish this goal, I provide a well-characterized component library, a biocircuit design methodology, and software design tools. I have built and characterized an initial cellular gate library with biochemical gates that implement the NOT, IMPLIES, and AND logic functions in E. coli cells. The logic gates perform computation using DNA-binding proteins, small molecules that interact with these proteins, and segments of DNA that regulate the expression of the proteins. I introduce genetic process engineering, a methodology for modifying the DNA encoding of existing genetic elements to achieve the desired input/output behavior for constructing reliable circuits of significant complexity. I demonstrate the feasibility of digital computation in cells by building several operational in-vivo digital logic circuits, each composed of three gates that have been optimized by genetic process engineering.; (cont.) I also demonstrate engineered intercellular communications with programmed enzymatic activity and chemical diffusions to carry messages, using DNA from the Vibrio fischeri lux operon. The programmed communications is essential for obtaining coordinated behavior from cell aggregates. In addition to the above experimental contributions, I have developed BioSPICE, a prototype software tool for biocircuit design. It supports both static and dynamic simulations and analysis of single cell environments and small cell aggregates. Finally, I present the Microbial Colony Language (MCL), a model for programming cell aggregates. The language is expressive enough for interesting applications, yet relies on simple primitives that can be mapped to the engineered biological processes described above.
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2001.; Includes bibliographical references (p. 130-138).
</summary>
<dc:date>2001-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Design and Evolution of Engineered Biological Systems</title>
<link href="https://hdl.handle.net/1721.1/21169" rel="alternate"/>
<author>
<name>Kelly, Jason</name>
</author>
<id>https://hdl.handle.net/1721.1/21169</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2005-08-11T03:54:14Z</published>
<summary type="text">Design and Evolution of Engineered Biological Systems
Kelly, Jason
To date, engineered biological systems have been constructed via a variety of ad&#13;
hoc approaches. The resulting systems should be thought of as pieces of art. Here, I&#13;
propose to explore how existing forward engineering approaches might be combined with&#13;
evolution to make routine the construction of engineered biological systems. I will&#13;
specify a procedure for construction of biological systems via screening of subcomponent libraries and rational re-assembly. I will develop tools to enable this approach including a high-throughput screening system to measure the input/output function of an arbitrary genetic device. I will apply this approach to construct a collection of ring oscillators and bi-stable switches. Furthermore, I anticipate that performance of these devices will decay&#13;
over time due to spontaneous errors in replication of the genetic information encoding the systems. As an engineer, I would like to be able to design systems with behavior that is predictable in the face of mutation and selection. I will explore mechanisms for increasing or decreasing the susceptibility of engineered biological systems to loss of function as a result of mutation.
</summary>
<dc:date>2005-08-11T03:54:14Z</dc:date>
</entry>
<entry>
<title>Idempotent Vector Design for Standard Assembly of Biobricks</title>
<link href="https://hdl.handle.net/1721.1/21168" rel="alternate"/>
<author>
<name>Knight, Thomas</name>
</author>
<id>https://hdl.handle.net/1721.1/21168</id>
<updated>2025-02-27T21:04:34Z</updated>
<published>2003-01-01T00:00:00Z</published>
<summary type="text">Idempotent Vector Design for Standard Assembly of Biobricks
Knight, Thomas
The lack of standardization in assembly techniques for DNA sequences forces each DNA assembly&#13;
reaction to be both an experimental tool for addressing the current research topic, and an experiment&#13;
in and of itself. One of our goals is to replace this ad hoc experimental design with a set of standard&#13;
and reliable engineering mechanisms to remove much of the tedium and surprise during assembly of&#13;
genetic components into larger systems.
</summary>
<dc:date>2003-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>DARPA BioComp Plasmid Distribution 1.00 of Standard Biobrick Components</title>
<link href="https://hdl.handle.net/1721.1/21167" rel="alternate"/>
<author>
<name>Knight, Thomas</name>
</author>
<id>https://hdl.handle.net/1721.1/21167</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2002-05-22T00:00:00Z</published>
<summary type="text">DARPA BioComp Plasmid Distribution 1.00 of Standard Biobrick Components
Knight, Thomas
This distribution consists of 300 ng aliquots of plasmid DNA for each of twelve components and compound constructs utilizing our idempotent assembly strategy. The dried DNA should be stable at room temperature for many weeks, but long term storage at -20 or -80 in the resealable foil pouch with desiccant is recommended. This document and much additional information, protocols, and&#13;
detailed sequences is or will be available from the site http://ks.ai.mit.edu
</summary>
<dc:date>2002-05-22T00:00:00Z</dc:date>
</entry>
<entry>
<title>Engineering the Interface Between Cellular Chassis and Integrated Biological Systems</title>
<link href="https://hdl.handle.net/1721.1/19813" rel="alternate"/>
<author>
<name>Canton, Bartholomew</name>
</author>
<id>https://hdl.handle.net/1721.1/19813</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2005-08-08T18:36:16Z</published>
<summary type="text">Engineering the Interface Between Cellular Chassis and Integrated Biological Systems
Canton, Bartholomew
The engineering of biological systems with predictable behavior is a challenging problem. One reason for this difficulty is that engineered biological systems are embedded within complex and variable host cells. To help enable the future engineering &#13;
of biological systems, I will study and optimize the interface between an engineered &#13;
biological system and its host cell or “chassis”. Other engineering disciplines use modularity to make interacting systems interchangeable and to insulate one system from another. Engineered biological systems are more likely to work as predicted if system function is decoupled from the state of the host cell. Also, specifying and standardizing the interfaces between a system and the chassis will allow systems to be engineered independent of chassis and allow systems to be interchanged between different chassis. To this end, I will build dedicated transcription and translation systems, independent from the equivalent host cell systems. In parallel, I will develop test systems and metrics to measure the interactions between an engineered system and its chassis. Lastly, I will explore methods to “port” a simple engineered system from a prokaryotic to a eukaryotic organism so that the system can function in both organisms.
</summary>
<dc:date>2005-08-08T18:36:16Z</dc:date>
</entry>
<entry>
<title>Fluorescence assay for polymerase arrival rates</title>
<link href="https://hdl.handle.net/1721.1/16618" rel="alternate"/>
<author>
<name>Che, Austin, 1979-</name>
</author>
<id>https://hdl.handle.net/1721.1/16618</id>
<updated>2022-01-13T07:54:29Z</updated>
<published>2004-01-01T00:00:00Z</published>
<summary type="text">Fluorescence assay for polymerase arrival rates
Che, Austin, 1979-
To engineer complex synthetic biological systems will require modular design, assembly, and characterization strategies. The RNA polymerase arrival rate (PAR) is defined to be the rate that RNA polymerases arrive at a specified location on the DNA. Designing and characterizing biological modules in terms of RNA polymerase arrival rates provides for many advantages in the construction and modeling of biological systems. PARMESAN is an in vitro method for measuring polymerase arrival rates using pyrrolo-dC, a fluorescent DNA base that can substitute for cytosine. Pyrrolo-dC shows a detectable fluorescence difference when in single-stranded versus double-stranded DNA. During transcription, RNA polymerase separates the two strands of DNA, leading to a change in the fluorescence of pyrrolo-dC. By incorporating pyrrolo-dC at specific locations in the DNA, fluorescence changes can be taken as a direct measurement of the polymerase arrival rate.
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, February 2004.; Includes bibliographical references (p. 87-100).; This electronic version was submitted by the student author.  The certified thesis is available in the Institute Archives and Special Collections.
</summary>
<dc:date>2004-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>BioJADE: A Design and Simulation Tool for Synthetic Biological Systems</title>
<link href="https://hdl.handle.net/1721.1/7115" rel="alternate"/>
<author>
<name>Goler, Jonathan A.</name>
</author>
<id>https://hdl.handle.net/1721.1/7115</id>
<updated>2025-02-27T21:04:34Z</updated>
<published>2004-05-28T00:00:00Z</published>
<summary type="text">BioJADE: A Design and Simulation Tool for Synthetic Biological Systems
Goler, Jonathan A.
The next generations of both biological engineering and computer engineering demand that control be  exerted at the molecular level. Creating, characterizing and controlling synthetic biological systems  may provide us with the ability to build cells that are capable of a plethora of activities, from  computation to synthesizing nanostructures. To develop these systems, we must have a set of tools not  only for synthesizing systems, but also designing and simulating them. The BioJADE project provides a  comprehensive, extensible design and simulation platform for synthetic biology. BioJADE is a graphical  design tool built in Java, utilizing a database back end, and supports a range of simulations using an  XML communication protocol. BioJADE currently supports a library of over 100 parts with which it can  compile designs into actual DNA, and then generate synthesis instructions to build the physical parts.  The BioJADE project contributes several tools to Synthetic Biology. BioJADE in itself is a powerful tool for  synthetic biology designers. Additionally, we developed and now make use of a centralized BioBricks  repository, which enables the sharing of BioBrick components between researchers, and vastly reduces  the barriers to entry for aspiring Synthetic Biologists.
</summary>
<dc:date>2004-05-28T00:00:00Z</dc:date>
</entry>
<entry>
<title>Fluorescence Assay for Polymerase Arrival Rates</title>
<link href="https://hdl.handle.net/1721.1/7112" rel="alternate"/>
<author>
<name>Che, Austin</name>
</author>
<id>https://hdl.handle.net/1721.1/7112</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>2003-08-31T00:00:00Z</published>
<summary type="text">Fluorescence Assay for Polymerase Arrival Rates
Che, Austin
To engineer complex synthetic biological systems will require modular design, assembly, and characterization strategies. The RNA polymerase arrival rate (PAR) is defined to be the rate that RNA polymerases arrive at a specified location on the DNA. Designing and characterizing biological modules in terms of RNA polymerase arrival rates provides for many advantages in the construction and modeling of biological systems.  PARMESAN is an in vitro method for measuring polymerase arrival rates using pyrrolo-dC, a fluorescent DNA base that can substitute for cytosine. Pyrrolo-dC shows a detectable fluorescence difference when in single-stranded versus double-stranded DNA. During transcription, RNA polymerase separates the two strands of DNA, leading to a change in the fluorescence of pyrrolo-dC. By incorporating pyrrolo-dC at specific locations in the DNA, fluorescence changes can be taken as a direct measurement of the polymerase arrival rate.
</summary>
<dc:date>2003-08-31T00:00:00Z</dc:date>
</entry>
<entry>
<title>Amorphous Computing</title>
<link href="https://hdl.handle.net/1721.1/5929" rel="alternate"/>
<author>
<name>Abelson, Harold</name>
</author>
<author>
<name>Allen, Don</name>
</author>
<author>
<name>Coore, Daniel</name>
</author>
<author>
<name>Hanson, Chris</name>
</author>
<author>
<name>Homsy, George</name>
</author>
<author>
<name>Knight, Thomas F., Jr.</name>
</author>
<author>
<name>Nagpal, Radhika</name>
</author>
<author>
<name>Rauch, Erik</name>
</author>
<author>
<name>Sussman, Gerald Jay</name>
</author>
<author>
<name>Weiss, Ron</name>
</author>
<id>https://hdl.handle.net/1721.1/5929</id>
<updated>2025-02-27T21:05:22Z</updated>
<published>1999-08-29T00:00:00Z</published>
<summary type="text">Amorphous Computing
Abelson, Harold; Allen, Don; Coore, Daniel; Hanson, Chris; Homsy, George; Knight, Thomas F., Jr.; Nagpal, Radhika; Rauch, Erik; Sussman, Gerald Jay; Weiss, Ron
Amorphous computing is the development of  organizational principles and programming  languages for obtaining coherent behaviors  from the cooperation of myriads of unreliable  parts that are interconnected in unknown,  irregular, and time-varying ways. The impetus  for amorphous computing comes from  developments in microfabrication and  fundamental biology, each of which is the  basis of a kernel technology that makes it  possible to build or grow huge numbers of  almost-identical information-processing units  at almost no cost. This paper sets out a  research agenda for realizing the potential of  amorphous computing and surveys some  initial progress, both in programming and in  fabrication. We describe some approaches to  programming amorphous systems, which are  inspired by metaphors from biology and  physics. We also present the basic ideas of  cellular computing, an approach to  constructing digital-logic circuits within living  cells by representing logic levels by  concentrations DNA-binding proteins.
</summary>
<dc:date>1999-08-29T00:00:00Z</dc:date>
</entry>
<entry>
<title>BioBricks++: Simplifying Assembly of Standard DNA Components</title>
<link href="https://hdl.handle.net/1721.1/39832" rel="alternate"/>
<author>
<name>Che, Austin</name>
</author>
<id>https://hdl.handle.net/1721.1/39832</id>
<updated>2025-02-27T21:04:33Z</updated>
<published>2004-06-09T23:50:11Z</published>
<summary type="text">BioBricks++: Simplifying Assembly of Standard DNA Components
Che, Austin
Construction of complex biological systems can require assembling many&#13;
modules together. However, existing assembly schemes are lacking in&#13;
generality, ease of use, or power to perform some desirable&#13;
operations. Currently, biological modules are most easily specified&#13;
and manipulated as DNA sequences. A general system, called&#13;
BioBricks++, for assembling and manipulating DNA modules is proposed.&#13;
BioBricks++ was inspired by the BioBricks assembly scheme but provides&#13;
for more possible module operations.&#13;
&#13;
BioBricks++ uses commercially available restriction enzymes and&#13;
standard biological techniques for assembling modules. The key to the&#13;
method is in the specification of the standard DNA module. Modules are&#13;
packaged with a standard prefix and suffix DNA sequence containing&#13;
several restriction enzyme sites, which are used for different module&#13;
operations.&#13;
&#13;
The following operations can be performed on all BioBricks++&#13;
modules. The most fundamental operation is the arbitrary assembly of&#13;
any two modules. In addition, the assembly of the two modules can be&#13;
made seamless, with no extra intervening sequence inserted between the&#13;
modules. Modules can also be easily reversed with no extra bases added&#13;
during the operation. Another useful capability is being able to&#13;
remove bases from either end of a module, allowing for operations such&#13;
as protein fusions or addition of tags.
</summary>
<dc:date>2004-06-09T23:50:11Z</dc:date>
</entry>
</feed>
